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Background: Reduction of the microbial load within the root canal system and intraradicular 
dentine to an acceptable level is crucial for successful endodontic therapy. Mechanical 
debridement significantly reduces the bacterial load, however, the adjunctive use of 
antimicrobial agents can further reduce the number of viable microorganisms. Currently used 
irrigants and medicaments have the potential to be cytotoxic by causing local tissue irritation 
or hypersensitivity. Antimicrobial peptides are polypeptides which can possess a broad-
spectrum of antimicrobial activity providing a host defence system to combat infections whilst 
being minimally toxic to host cells. BM2 is a D-decameric cationic peptide. The antimicrobial 
potential of BM2 in a medium suitable for use as an intracanal medicament needs to be 
investigated.  
 
Aim: The aim of the present study was to assess the in vitro antimicrobial efficacy of BM2 in 
an injectable polymer gel matrix against common endodontic pathogens. 
 
Materials and Methods: Strains of Candida albicans, Streptococcus gordonii, Streptococcus 
mutans, and Enterococcus faecalis were grown from frozen glycerol stocks and confirmed. 
Dilutions of BM2 were prepared in aqueous solution and the minimum inhibitory concentration 
(MIC) determined using the broth microdilution assay. The minimum bactericidal/fungicidal 
concentration (MBC/MFC) was established by subculturing the broth dilution onto culture 
media. Poloxamer 407 (P407) gels, at 25% (w/v) were loaded with BM2 and the gel stability 
evaluated. The in vitro release profile of BM2 from the P407 formulations and the gel 
dissolution profile were obtained. The antimicrobial efficacy of BM2 in a P407 gel formulation 
was assessed on planktonic cell cultures and on 24 h monospecies biofilms using a crystal violet 
biofilm assay over 72 h. Comparisons were made between BM2 in aqueous solution, P407 gel 
alone, BM2 in P407 gel formulations, and saturated calcium hydroxide. 
 
Results: Aqueous BM2 at 128 µg/mL completely inhibited the growth of all four strains after 
24 h exposure.  S. mutans NG8 was the most susceptible (MIC 4 µg/mL, MBC 8 µg/mL) while 
E. faecalis JH2-2 was the least susceptible (MIC 64 µg/mL). P407 gels containing BM2 were 
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prepared with no marked alteration to the stability of P407. BM2 release increased with time 
and demonstrated a linear correlation with P407 dissolution. BM2 retained its antimicrobial 
activity when incorporated into P407 gels exhibiting bacteriostatic activity. S. mutans NG8 was 
the most susceptible to P407 with BM2 (MIC 32 µg/mL) while E. faecalis JH2-2 was the most 
resistant (MIC >512 µg/mL). The MIC values of BM2 in P407 were 8-fold higher than those 
required for aqueous BM2 and although higher concentrations were required, it demonstrated 
more sustained effects on cell cultures over 72 h. BM2 incorporated into P407 gels gave dose-
dependent growth impairment and significantly disrupted biofilm detachment at 512 µg/mL. 
Saturated calcium hydroxide inhibited growth of the S. mutans 24 h biofilm, slowed growth of 
S. gordonii and C. albicans biofilms, but was ineffective against the E. faecalis biofilm.  
 
Conclusions: BM2 in a P407 gel possesses antimicrobial activity against planktonic cultures 
and monospecies biofilms of C. albicans, S. gordonii, S. mutans and E. faecalis at 
concentrations 8-fold higher than that in solution. Antimicrobial activity was greater than 
saturated calcium hydroxide. Within the limitations of this study, BM2 in a polymer gel has 
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Chapter 1:   Introduction 
Microorganisms play a vital role in the development and progression of pulp and periapical 
disease (Kakehashi et al. 1965, Möller et al. 1981). Reduction of the microbial load within the 
root canal system and intraradicular dentine to an acceptable level is crucial for successful 
endodontic therapy. This is accomplished through mechanical debridement and chemical 
irrigation, which aims to remove vital or necrotic tissue and eliminate infection (Byström & 
Sundqvist 1981, Vertucci 1984). Microorganisms have the ability to survive in areas not 
directly accessible to conventional methods of cleaning and shaping. Once in the root canal 
system, bacteria can invade radicular dentinal tubules where they are shielded from 
instrumentation and irrigation. The placement of intracanal medicaments may facilitate further 
disinfection of the complex root canal system and radicular dentinal tubules between 
appointments (Byström et al. 1985, Sjögren et al. 1991, Shuping et al. 2000).   
Persistent or emerging post-treatment disease can, however, occur despite thorough chemo-
mechanical debridement and the placement of antimicrobial dressings (Nair et al. 1990, Nair 
2004). Species such as Enterococcus faecalis have frequently been isolated from root canals of 
teeth that have undergone root canal treatment, even under the most ideal conditions (Molander 
et al. 1998, Sundqvist et al. 1998).  It has been found to show resistance to most intracanal 
medicaments, particularly calcium hydroxide (Byström et al. 1985).  
Current intracanal medicaments used are toxic to the host tissues or have a limited bactericidal 
effect. The development of an antimicrobial agent with low host toxicity and which is effective 
at reducing the microbial load in biofilms would be advantageous. 
Antimicrobial peptides (AMPs) are a diverse group of molecules expressed by many life forms 
in host defence settings (Brogden 2005). They are important effector molecules and a major 
component of the innate immune system of most living organisms (Jenssen et al. 2006). Various 
AMPs have been studied as alternative antibiotics due to their potency, rapid onset of action, 
and broad-spectrum activity against gram-negative and gram-positive bacteria, viruses, fungi, 
and parasites (Dosler & Mataraci 2013). Due to their antimicrobial selectivity and unique mode 
of action, these peptides can be promising candidates for the development of a new class of 
antimicrobials. 
Preliminary studies using the synthetic cationic peptide, BM2, in solution found microbicidal 
activity against planktonic cultures and biofilms of endodontic pathogens. The clinical 
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suitability of an aqueous delivery system may, however, be compromised in a root canal model. 
In situ polymer gel-forming systems have been used to prolong the residence time of drugs and 
improve bioavailability. The thermoresponsive class of gels provides the advantage of 
convenient administration by involving a phase transition upon change in temperature. The use 
of a thermoresponsive gel may be beneficial for delivery of an antimicrobial into the root canal 
system for use as an intracanal medicament. The aim of this thesis is to evaluate the in vitro 
antimicrobial efficacy of BM2 in a thermoresponsive gel matrix.  
The next chapter of this thesis will include a review of the literature including an overview of 
root canal microbiology, intracanal medications used in endodontics, antimicrobial peptides, 





Chapter 2:   Literature Review 
2.1 Overview of root canal microbiology 
The oral cavity is populated by a diverse range of bacteria with the vast majority being 
considered harmless. Most of these are tolerated by our immune system. Some species may be 
opportunistic under certain conditions, resulting in various diseases including pulp and 
periradicular disease. The occurrence of disease depends on the virulence of the 
microorganisms, its population, and the resistance of the host. Strategies to control such disease 
must be based on a thorough knowledge of their microbiological basis.  
The role of bacteria in the pathogenesis of endodontic infections has been extensively studied. 
Bacteria have been shown to be essential for the progression of apical periodontitis (Möller et 
al. 1981, Fabricius et al. 1982a, Ricucci & Siqueira Jr 2010). Kakehashi et al. (1965) 
demonstrated that pulp and periapical disease developed in surgically exposed rat molar pulps 
only when bacteria were present in the oral cavity. In a germ-free environment on the other 
hand, exposed pulps remained healthy and demonstrated a reparative response involving 
dentinogenesis.  
The oral microflora has over 700 indigenous species but only a finite group are responsible for 
infection of the pulp. It was initially thought that gram-positive aerobic bacteria were the most 
prevalent microorganisms in infected pulps. However, this was due to the use of aerobic 
incubation chambers which favoured the growth of facultative aerobes and hence, anaerobic 
species such as Staphylococcus and Bacteroides were less frequently isolated (Leavitt et al. 
1958). Environmental and symbiotic relationships within the root canal system pose challenges 
for cultivation. Advances in sampling and culturing techniques have led to a better 
understanding of the microbiota harboured in the root canal system (Möller et al. 1981). The 
development of strict anaerobic culturing and transport methods (Kantz & Henry 1974, 
Wittgow Jr & Sabiston Jr 1975, Sundqvist 1976) and the advent of polymerase chain reaction 
(PCR) techniques have led to the recognition of anaerobic microorganisms as important 
endodontic pathogens. Facultative anaerobic bacteria such as streptococci and lactobacilli have 
been demonstrated in infected pulps (Baumgartner & Falkler 1991). Endodontic infections are 
now well established as polymicrobial infections (Zavistoski et al. 1980, Sundqvist 1992).  
Streptococci and Actinomyces species are major components of dental plaque (Nyvad & Kilian 
1987, Jenkinson & Lamont 1997) and may be responsible for the initiation of pulpal infection 
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through invasion of dentinal tubules. As the environmental conditions change, so does the 
specificity of the root canal flora. The relative proportions of anaerobic microorganisms 
increases with time as the oxygen tension declines and the nutritional availability changes. This 
occurs due to the consumption of oxygen by microorganisms and the development of a low 
reduction-oxidation potential favouring the growth of more fastidious microorganisms. Further 
oxygen supply is lacking due to the loss of blood circulation associated with a necrotic pulp. 
Although the availability of carbohydrates declines within the root canal system, 
microorganisms are able to derive their nutrients from other sources. This includes degradation 
of remaining necrotic pulp tissue and endogenous proteins and glycoproteins which are derived 
through influx of exudate from the periapical tissues. Furthermore, studies have shown that 
metabolism of one species found in the root canal supplies essential nutrients for the growth of 
other species (Sundqvist 1992, Marsh 2005). Consequently, the earlier colonising 
microorganisms become outnumbered by obligate anaerobic species such as Bacteroides, 
Fusobacterium, Porphyromonas, Peptostreptococcus, Prevotella, and Veillonella (Sundqvist 
1976, Zavistoski et al. 1980, Möller et al. 1981, Fabricius et al. 1982a, 1982b, Byström & 
Sundqvist 1983). The isolation of multiple species has demonstrated the complex nature of the 
root canal microbiota with selective pressures allowing certain species to thrive in symbiotic 
relationships while others cannot survive due to antagonistic interactions. 
Fungi are considered commensal organisms of the oral cavity, however, studies have cultivated 
fungi from infected root canals (Macdonald et al. 1957, Sen et al. 1995, Baumgartner et al. 
2000). Fungi such as Candida spp. have been shown to become pathogenic in certain 
environments, the most commonly isolated strain being Candida albicans (Baumgartner et al. 
2000, Siqueira Jr & Rôças 2009). Several studies have associated the presence of certain fungal 
species with root-filled teeth with chronic apical periodontitis (Waltimo et al. 1997, Cheung & 
Ho 2001, Peciuliene et al. 2001). 
Gram-negative bacteria within the root canal system such as black-pigmented Bacteroides or 
Fusobacterium undergo lysis and release endotoxins from the cell wall (Dahlén & Bergenholtz 
1980). Previous studies on lipopolysaccharides extracted from gram-negative strains showed 
inflammatory reactions when injected under the skin (Dahlén & Hofstad 1977), with the degree 
of inflammation showing strain-dependence. Later studies identified a correlation between the 
number of particular bacteria in the root canal system and the endotoxic activity (Dahlén & 
Bergenholtz 1980, Schein & Schilder 2006). These endotoxins have been shown to play a role 
in the induction and development of periapical lesions (Dwyer & Torabinejad 1981, Pitts et al. 
1982). Infected pulps have been shown to induce inflammatory reactions in the periapical 
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tissues. This appears to be a prerequisite for the development of apical periodontitis (Möller et 
al. 1981, Eggink 1982).  
 
2.1.1 Post-treatment disease 
The microbiota harboured within the root-filled tooth associated with post-treatment disease 
differs from that in primary root canal infections. Intraradicular infection has been deemed to 
be the most common cause of post-treatment disease with microorganisms commonly persisting 
in the apical portions of obturated root canals (Nair et al. 1990, Siqueira Jr 2001) and in the 
dentinal tubules.  
Primary root canal infections are generally made up of several microbial species, as mentioned 
previously (Wittgow Jr & Sabiston Jr 1975, Möller et al. 1981, Baumgartner & Falkler 1991, 
Gomes et al. 1996b), with high numbers of obligate anaerobes. On the other hand, the 
microflora of persistent or emerging disease comprises predominantly gram-positive facultative 
anaerobic bacteria with one or two strains frequently isolated (Sundqvist 1976, Molander et al. 
1998, Pinheiro et al. 2003). Compared to obligate anaerobes, facultative anaerobes are able to 
withstand antimicrobial agents better and consequently, can persist after root canal treatment. 
The ability of some species to survive root canal treatment may be related to their limited 
nutritional requirements. 
Enterococcus spp. have been implicated in primary root canal infections but have only been 
found to make up a small proportion of the initial flora (Weiger et al. 1995, Le Goff et al. 1997). 
The most commonly isolated strain has been found to be Enterococcus faecalis. Studies have 
shown that Enterococcus spp. have the potential to evade current treatment protocols and have 
been frequently cultivated from obturated root canals of teeth with persistent periapical pathosis 
(Molander et al. 1998, Sundqvist et al. 1998, Hancock III et al. 2001), even when root canal 
treatment is carried out under ideal conditions. It has been found that E. faecalis may be a 
commensal microorganism of the root-filled tooth which survives initial treatment but may not 
be causative of failure (Fabricius et al. 1982a, Kaufman et al. 2005). The idea that E. faecalis 
may increase the survival and pathogenicity of other root canal microbiota has been shown by 
Möller et al. (2004). E. faecalis possesses the ability to survive as a planktonic organism without 
the need for synergism from other species. It has been found to colonise and adapt to the harsh 
environment of the dentinal tubule (Haapasalo & Ørstavik 1987). This has been attributed to a 
number of reasons such as its ability to adhere to host cells and extracellular matrix, competition 
with other bacterial species, its ability to resist host defence mechanisms, and the production of 
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toxins resulting in damage. Once established in the root canal system, E. faecalis can be difficult 
to eradicate as intracanal medicaments such as calcium hydroxide have been found to be 
ineffective at killing it (Stevens & Grossman 1983, Byström et al. 1985, Haapasalo & Ørstavik 
1987, Ørstavik & Haapasalo 1990, Safavi et al. 1990, Saleh et al. 2004). Some studies have 
suggested more effective agents to eliminate it such as chlorhexidine (Gomes et al. 2003) and 
camphorated paramonochlorophenol (Byström et al. 1985, Ørstavik & Haapasalo 1990, Safavi 
et al. 1990). This ability of E. faecalis to tolerate and adapt to the environmental stresses may 
explain its persistence and pathogenicity in root canal infections (Love 2001). 
Other species which have frequently been cultivated in post-treatment disease include 
Propionibacterium, Prevotella, Peptostreptococcus, Eubacterium, Lactobacillus spp, 
Streptococcus spp (Gomes et al. 1996a, Molander et al. 1998, Sundqvist et al. 1998). Fungal 
species have also been isolated from root-filled teeth with chronic apical periodontitis (Waltimo 
et al. 1997, Sundqvist et al. 1998, Hancock III et al. 2001). 
 
2.1.2 Biofilms 
A biofilm is a sessile and diverse community of microorganisms embedded in an extracellular 
polysaccharide matrix that is attached to a surface (Costerton et al. 1999). Bacterial populations 
exist as separate microcolonies forming ecological niches. This synergistic relationship allows 
microorganisms to establish a broader habitat range for growth, increase metabolic diversity 
and efficiency, enhance pathogenicity, and allows them to withstand environmental stresses, 
antimicrobial agents, and host immune responses (Marsh 2005). It constitutes one of the main 
strategies for bacterial survival. Understanding the formation of biofilms and the properties of 
microorganisms in a biofilm community is essential for the development of effective 
management strategies.  
Biofilm formation is a dynamic process. It involves attachment of planktonic cells initially by 
weak van der Waals forces between the bacteria and the host surface followed by receptor-
mediated interactions between the host and microbial cell surface adhesins. Initial binding 
occurs between planktonic cells and a complex proteinaceous pellicle which acts as an adhesive 
substratum for these primary bacterial colonisers (Love 2010). Streptococcal strains are among 
the early colonisers and provide additional binding sites for the subsequent attachment of gram-
positive and -negative microorganisms (Svensäter & Bergenholtz 2004). Further growth and 
aggregation results in the development of microcolonies. Channels produced as cells proliferate 
and aggregate help to distribute plasmids, nutrients, gases, and quorum sensing molecules (Leid 
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2009, Dufour et al. 2010). Strong inter-relationships develop between different microbial 
species. Population shifts in the flora are produced as a result of these interactions as well as 
environmental changes and selective pressures within the complex root canal system (Sundqvist 
1992). 
Studies of the endodontic microbiota involved in primary and secondary infections have 
demonstrated that bacterial colonisation of the root canal system resembles that of a biofilm 
structure (Noiri et al. 2002, Siqueira Jr et al. 2002, Ricucci & Siqueira Jr 2010). Bacterial 
aggregations consisting predominantly of cocci and rods have been demonstrated on the walls 
of infected root canals and in the dentinal tubules (Nair 1987, Molven et al. 1991, Perez et al. 
1993, Sen et al. 1995). 
Microorganisms in biofilms have several advantages over their planktonic state. They have a 
stronger pathogenic potential and become much less susceptible to antimicrobial agents through 
quorum sensing and reduced diffusion. Quorum sensing signalling occurs by the diffusion of 
molecules which modify gene expression and optimise phenotypic properties of bacteria in root 
canals. Bacteria are thus able to resist host immune responses by limiting penetration of 
leukocytes and their bactericidal products into the biofilm architecture (Leid 2009). 
Microorganisms in mature biofilms have proved difficult to eradicate, being 10-1000 times 
more resistant to the effects of antimicrobial agents compared to planktonic cells (Ceri et al. 
1999). The dense polysaccharide matrix provides a barrier, limiting the diffusion of 
antimicrobials into the deeper layers of the biofilm. The lack of nutrients results in a phase 
transition from active to quiescent, slowing bacterial growth and increasing resistance to 
antimicrobials (Gilbert et al. 1997, Desai et al. 1998). Therapeutic measures should consider 
the reduced efficacy of antimicrobial agents on microorganisms in a biofilm community. 
 
2.1.3 Invasion of dentinal tubules 
Several hundred commensal organisms exist within the oral cavity, however, only certain 
species are able to survive the environmental conditions within the dentinal tubules and the root 
canal space (Wittgow Jr & Sabiston Jr 1975, Sundqvist 1976). Although streptococci, 
lactobacilli and Actinomyces have been shown to be prevalent in high numbers in dental plaque 
(Sundqvist 1976, Möller et al. 1981, Jenkinson & Lamont 1997), the infected root canal is 
dominated by obligate anaerobic bacterial species of Fusobacterium, Peptostreptococcus, 
Eubacterium, Propionibacterium, Veillonella, Wolinella, Prevotella, and Porphyromonas 
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(Fabricius et al. 1982b, Sundqvist & Figdor 2003) and occasionally by fungal species such as 
C. albicans (Baumgartner et al. 2000). Bacteria and their byproducts are able to diffuse through 
the coronal dentinal tubules towards the pulp when there is a breach of the dentino-enamel 
junction, exposing the dentine to the oral cavity (Love & Jenkinson 2002). The pulp-dentine 
complex reacts to the invading bacteria with immunocompetent cells. When the host defence 
becomes overwhelmed, pulp disease ensues, and if left untreated, this can lead to periapical 
disease. Once bacteria become established within the root canal space, they can penetrate the 
radicular dentinal tubules to varying depths depending on the tubule dimensions, the clinical 
history of the tooth, and the virulence of the bacteria.  
The tubular structure of dentine is responsible for its permeability, providing channels for 
bacteria between the dentine and pulp. The tubule contains odontoblastic processes, nerve 
fibres, and unmineralised collagen fibrils (Dai et al. 1991, Siqueira Jr et al. 1996) which direct 
the flow of dentinal fluid in a vital tooth (Michelich et al. 1980). Degeneration of odontoblastic 
processes and a loss of collagen fibres in a non-vital tooth may be responsible for the reduction 
in fluid flow and a subsequent decrease in bacterial invasion due to the loss of nutrients. The 
composition of tubular fluid is not well understood but is believed to contain proteins such as 
albumin, immunoglobulins, and fibrinogen. In vitro studies have shown a decrease in fluid flow 
associated with these molecules to reduce diffusion of microorganisms to the pulp (Pashley et 
al. 1982, Hahn & Overton 1997). Antibodies may increase in the dentinal fluid in the case of 
bacterial invasion of a vital tooth (Okamura et al. 1980, Nagaoka et al. 1995). 
The invasion of coronal dentine by microorganisms from the oral cavity occurs in the presence 
of carious lesions, restorative or periodontal procedures, tooth wear, cracks or dental trauma 
(Love 1996, 2004). Once bacteria reach the dentino-enamel junction, they are able to travel 
through the tubules and multiply to evoke pulpal inflammatory responses. The diameter of the 
tubule influences the depth of invasion. They can range from 0.5 µm at the periphery to 3.0 µm 
at the pulpal surface (Garberoglio & Brännström 1976, Gomes et al. 1996a). Microorganisms 
able to colonise the root canal space are approximately one third the diameter of the coronal 
dentinal tubules. Different regions of carious dentine contain different proportions of bacterial 
components in their microflora due to the nutritional requirements of the bacteria. Greater 
numbers of bacteria are isolated from the more superficial layers of carious dentine. Intrapulpal 
pressures resulting in outward fluid flow from the pulp to the periphery may play a role in 
mechanically hindering bacterial ingrowth into the exposed dentinal tubules (Johnson et al. 
1973, Olgart et al. 1974).  
9 
 
Once bacteria infiltrate the root canal system, they are able to permeate through the radicular 
dentinal tubules where they are protected from the action of mechanical debridement and 
antimicrobial agents. Recalcitrant pulpal infection may be caused by the retention of 
microorganisms in the radicular dentinal tubules (Akpata & Blechman 1982, Haapasalo & 
Ørstavik 1987, Safavi et al. 1990). In vitro studies have attempted to demonstrate the 
penetration of dentinal tubules by a diverse range of microorganisms typically seen in infected 
pulps. Akpata and Blechman (1982) inoculated extracted human teeth with two obligate 
anaerobic bacteria – Bacteroides melaninogenicus and Peptostreptococcus asaccharolyticus – 
and two facultative anaerobic bacteria – E. faecalis and Streptococcus sanguis (now sanguinis) 
– and related the depth of invasion to the time of incubation and growth rate of the 
microorganisms. Depth of penetration differs along the root surface with higher numbers of 
bacteria invading the cervical third of the root compared to the apical (Akpata & Blechman 
1982) and differs amongst species depending on the size and virulence (Safavi et al. 1990, 
Siqueira Jr et al. 1996). Microbial penetration has been found to range from 50 to 600 µm 
(Haapasalo & Ørstavik 1987, Ørstavik & Haapasalo 1990, Safavi et al. 1990, Perez et al. 1993). 
Studies have demonstrated that bacterial invasion of dentinal tubules occurs more readily when 
the smear layer is removed as debris may occlude the orifices of the tubules and reduce 
permeability (Michelich et al. 1980, Meryon et al. 1986, Drake et al. 1994). Authors have 
suggested that the presence of cementum on the external surface of the root affects the ability 
of microorganisms to penetrate the radicular tubules from the pulpal surface (Haapasalo & 
Ørstavik 1987, Safavi et al. 1990). The loss of cementum increases the patency of the tubules 
and enhances the penetration of microorganisms. 
Conventional mechanical debridement significantly reduces the bacterial load of the root canal. 
However, microorganisms present within the dentinal tubules may be inaccessible. The 
adjunctive use of antimicrobial agents is likely to further reduce the number of viable 
microorganisms harboured in the canal and the dentinal tubules. The penetration of currently 
used medicaments into the dentinal tubules however, varies greatly and has been questioned 
(Wang & Hume 1988, Cwikla et al. 2005). This will be discussed in the following section. 
 
2.2 Root canal medication 
The concept of chemo-mechanical preparation, utilising a chemical irrigant as an adjunct to 
mechanical instrumentation, maximises soft tissue and microorganism removal. Although this 
can greatly reduce the bacterial population, bacteria can survive and multiply within the 
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complex root canal system and dentinal tubules between appointments (Gomes et al. 1996b). 
Previous studies have found that bacteria were still harboured in the root canals of teeth treated 
with mechanical instrumentation and an antimicrobial irrigant (Byström & Sundqvist 1981, 
1983, 1985). The application of calcium hydroxide as an intracanal dressing helped to eliminate 
surviving bacteria (Byström et al. 1985). Thus, effective reduction of bacteria cannot be 
achieved without the additional use of intracanal medicaments.   
Intracanal medicaments have been advocated for many purposes. Current medicaments serve 
to eliminate or reduce microorganisms remaining after instrumentation, reduce inflammation 
of the periapical tissues and pulp remnants, and prevent post-operative pain (Walton 1984, 
Chong & Pitt Ford 1992). Furthermore, they can be used to promote healing of calcified tissues 
(Heithersay 1975) and can be used to manage inflammatory root resorption (Pierce & Lindskog 
1987). 
The properties of an ideal intracanal medicament are well documented (Martin 1979). The ideal 
medicament should have a wide and prolonged antimicrobial spectrum, be non-irritating to the 
periapical tissues, be capable of dissolving pulp remnants (Andersen et al. 1992, Silver 1997), 
remain stable in solution, be easily introduced into the canal, be miscible with water so it may 
penetrate the dentinal tubules, be easily washed from the canal prior to obturation, and be non-
staining. To date, no single medicament possesses these ideal properties and consequently, 
many different agents have been tried and tested as intracanal medicaments. Some of the many 
medicaments that have been used include paraformaldehyde, parachlorophenol, camphorated 
paramonochlorophenol, formocresol, cresol, creosote, thymol, eugenol, glutaraldehyde 
metacresylacetate (Cresatin), sodium hypochlorite, iodine compounds, chlorhexidine 
gluconate, chlorine compounds, quaternary ammonium compounds, Cresophene, calcium 
hydroxide non-setting paste, Ledermix® paste, Septomixine Forte paste, Pulpomixine paste, and 
Odontopaste® (Abbott 1990, Kawashima et al. 2009).  The most common, currently used 
intracanal medicaments are discussed in detail below.  
 
2.2.1 Calcium hydroxide 
Calcium hydroxide is the most commonly used medicament in root canal treatment. It was first 
introduced in endodontics by Hermann in 1920 and was initially used in vital pulp therapy.  
It is a strong alkaline substance with a pH of approximately 12.5. Most pathogens involved in 
pulp and periapical disease are unable to survive this highly alkaline environment and are 
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therefore eliminated when in contact with calcium hydroxide (Heithersay 1975, Byström et al. 
1985). It is a white odourless powder and has low solubility in water. It must be mixed with a 
liquid for ease of placement into the canal. Calcium hydroxide dissociates into calcium and 
hydroxyl ions in an aqueous environment. The efficacy of calcium hydroxide is highly 
dependent on the availability of hydroxyl ions. These ions damage the phospholipid component 
of bacterial cell membranes, react with bacterial DNA inhibiting its replication, and result in 
the denaturation of proteins.  
In order to reduce the bacterial load sufficiently, hydroxyl ions must be able to diffuse through 
the dentinal tubules at sufficient concentrations. Nerwich et al. (1993) studied the diffusion 
dynamics of calcium hydroxide by measuring pH changes across different levels in the radicular 
dentine. They found that calcium hydroxide diffused into the inner radicular dentinal tubules 
within a few hours but took up to 7 days to reach the outer tubules. Ørstavik and Haapasalo 
(1990) found that disinfection of the dentinal tubules with calcium hydroxide can take up to 10 
days. The ability of the hydroxyl ions to diffuse into the tubules is affected by tubule diameter 
and density which decreases as the distance from the root canal increases. In addition to this, 
dentine has the capacity to buffer the hydroxyl ions by the presence of hydroxyapatite (Wang 
& Hume 1988).  
Calcium hydroxide was shown to have a superior antibacterial effect compared to camphorated 
paramonochlorophenol and camphorated phenol (Byström et al. 1985). Stevens and Grossman 
(1983), however, found that it was inferior to camphorated paramonochlorophenol in 
eliminating E. faecalis in experimentally infected root canals in cats. Other studies have also 
supported the finding that calcium hydroxide is ineffective at eliminating E. faecalis (Byström 
et al. 1985, Ørstavik & Haapasalo 1990, Safavi et al. 1990, Evans et al. 2002). Microbiological 
investigations have demonstrated the presence of fungal species in recalcitrant apical 
periodontitis. An in vitro study by Waltimo et al. (1999) demonstrated the resistance of Candida 
spp. to calcium hydroxide. This highlights the problem of relying upon current intracanal 
medicaments such as calcium hydroxide as no medicament to date is effective against all 
microorganisms in the root canal system.  
 
2.2.2 Ledermix® paste 
Ledermix® paste is another medicament occasionally used in root canal treatment, consisting 
of 1% triamcinolone acetonide (corticosteroid) and 3% demeclocycline (antibiotic). It has 
commonly been used in cases of severe inflammation for relief of pain (Ehrmann 1965, 
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Ehrmann et al. 2003), for inflammatory root resorption (Pierce & Lindskog 1987), and as an 
antibacterial agent (Taylor et al. 1989). Topical corticosteroids have been advocated for use as 
anti-inflammatory agents in root canal treatment.  
Studies have highlighted the issues surrounding the use of Ledermix® paste, specifically the 
discolouration associated with its use (Kim et al. 2000). This has been attributed to the 
tetracycline component which has been shown to result in changes in colour of the hard tissues. 
In addition to this, demeclocycline acts as a bacteriostatic rather than a bactericidal agent.  
A study by Abbott et al. (1988) on the diffusion of corticosteroid and tetracycline tracer 
molecules through dentine reported a peak in concentration of demeclocycline through the 
radicular dentinal tubules within the first day after placement. This declined exponentially over 
7 days, suggesting that demeclocycline may only be effective against microorganisms in the 
first few days. 
 
2.2.3 Odontopaste® 
An alternative intracanal medicament to Ledermix® paste was developed, called Odontopaste®, 
which has the benefit of being non-staining (Adamidou 2010, Chen et al. 2012). It is a zinc 
oxide-based paste containing 1% triamcinolone acetonide as the corticosteroid and 5% 
clindamycin hydrochloride as the antibiotic. It has similar properties to Ledermix® paste in that 
it is bacteriostatic, reduces inflammation, and reduces post-operative pain. Clindamycin has 
been shown to be effective against many endodontic pathogens but its effectiveness compared 
to calcium hydroxide in inhibiting bacterial growth is still unclear (Molander et al. 1990). 
Odontopaste® is being increasingly used, however, literature on its use is still limited.  
 
2.3 Antimicrobial peptides 
The extensive use of antibiotics to target infections has been thought to be the cause of an 
increase in antibiotic resistance among gram-negative, gram-positive, and fungal pathogens 
(Brogden et al. 2003). Concerns have been raised about the progressive decrease in efficacy of 
antibiotics. The development of new classes of anti-infective therapeutics which are fast-acting, 
possess a broad-spectrum, have limited side effects, and which overcome this emerging 
problem of antibiotic resistance is warranted.  
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The host response to invasion by harmful pathogens involves activation of the innate immune 
system with production of a diverse range of cells including phagocytic neutrophils, 
macrophages, and leukocytes such as mast cells. A major component of this system is the 
synthesis of antimicrobial peptides (AMPs) within granules of resident neutrophils. AMPs are 
polypeptides found in many life forms, ranging from bacterial and fungal cells to human. The 
induction of these peptides may be a primeval equivalent of the immune response (Hancock 
1997), and is used as a first line of immune defence by many organisms. In mammals, including 
humans, AMPs are found in neutrophils and on the surface of the tongue, trachea, lungs and 
upper intestine (Giacometti et al. 2000). They are thought to be major factors in antibacterial 
defence on mucosal surfaces (Hancock 1997).  Their antimicrobial potency and specificity has 
therapeutic potential in the treatment of infections, including infections resistant to 
conventional antibiotics (Falla & Hancock 1997, Giacometti et al. 1998, De Lucca & Walsh 
1999, Giacometti et al. 2000). Due to their surface charge, they do not bind to the cholesterol-
rich and neutral plasma membrane surfaces (Monk et al. 2005). As a result, they do not attack 
host cells and are minimally toxic to host tissues (Brogden 2005, Klotman & Chang 2006, Aerts 
et al. 2008).  
AMPs have been a popular topic of research with the discovery of over 800 naturally occurring 
peptides, especially within the realm of medicine. Although their existence has been known for 
several decades, recent evidence has drawn attention to the potential role of AMPs in preventing 
the onset of infection by pathogenic microorganisms (Giacometti et al. 1999, Turner et al. 2004, 
Tong et al. 2010). Some of these peptides possess a broad-spectrum of antimicrobial activity 
against gram-positive and -negative bacteria, viruses, mycoplasma, and fungi (Hancock 1997), 
providing a host defence system to combat infections whilst being minimally toxic to host cells 
(Giacometti et al. 1999). Certain AMPs are induced by bacterial products in the case of acute 
inflammation. 
AMPs are typically short, consisting of 12 to 50 amino acid residues and carry a net positive 
charge of 2 to 9 (Wang & Wang 2004, Brown & Hancock 2006, Jenssen et al. 2006). These 
cationic AMPs are ribosomally synthesised amphipathic molecules folded in three dimensions 
with a hydrophobic face or core, bordered by positively charged hydrophilic amino acid 
residues.  A diverse range of AMPs have been reported and these have been classified into four 
main classes based on their structure: alpha (α) helices, beta (β) sheets, extended helices, and 
loop structures (Jenssen et al. 2006). Some peptides, such as the AMP magainin secreted from 
the skin of the African clawed frog Xenopus laevis (Zasloff 1987), only adopt an amphipathic 
α-helical structure once they enter a membrane (Zasloff 2002).  
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Despite many AMPs being potent antimicrobials, the microbicidal effect of some have been 
questioned. This effect may be negated by physiological conditions, degradation by host 
proteases, the presence of negatively charged ions such as glycosaminoglycans or salt, and low 
local peptide concentrations (Jenssen et al. 2006). As a result, thousands of cationic peptides 
have been synthesised using protein chemistry and recombinant DNA technology in order to 
optimise activity (Hancock 1997). Although expensive to produce, some of these synthetic 
congeners of naturally occurring AMPs have been shown to be promising candidates for 
antimicrobial therapy (Brogden et al. 2003). 
 
2.3.1 Mechanism of action 
The precise mechanism of action of AMPs remains to be determined. The structure and 
composition of most AMPs allow them to bind with high affinity to the lipid in the membrane, 
resulting in the displacement of lipids, alteration of the membrane structure creating “pores”, 
with subsequent entry of the AMP into the target cell (Matsuzaki 1999, Shai 1999, Yang et al. 
2000). Due to their mode of interaction with cell membranes, AMPs preferentially target 
enveloped viruses, gram-negative and gram-positive bacteria, fungi, and parasites rather than 
host membranes. The formation of channels eventually results in cell death (Falla & Hancock 
1997). AMPs do not always form pores when binding to membranes. Some may remain in a 
functionally inactive state where they are adsorbed on lipid headgroups while others are active 
and able to form pores in some cell membranes and not others (Yang et al. 2001). 
The most commonly studied class of AMPs are those possessing antibacterial activity. Initial 
attraction to bacterial surfaces occurs through electrostatic bonding between peptides and 
bacterial surface structures. It is likely that cationic AMPs, by virtue of their positive charge, 
are attracted to the net negative charges which exist on the outer envelope of gram-negative and 
gram-positive bacteria (Brogden 2005). The available evidence suggests that AMPs recognise 
and target bacterial lipopolysaccharide and lipoteichoic acid, exerting their cell-lytic effect by 
binding to the cell surface and permeating the membrane (Dathe & Wieprecht 1999). AMPs 
must traverse a lipopolysaccharide layer before interacting with the outer membrane in gram-
negative bacteria and traverse polysaccharides, lipoteichoic acids, and teichoic acids before 
interaction can occur with the cytoplasmic membrane in gram-positive bacteria (Brogden 
2005). 
Knowledge of the mechanism of action of peptides possessing antifungal activity is limited. It 
is believed that antifungal peptides, such as the histatins, involve either fungal cell lysis, 
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membrane permeabilisation, disruption of the structure of the cell membrane, interference with 
cell wall synthesis, and/or direct effects on intracellular targets such as mitochondria or DNA 
and RNA metabolism (De Lucca & Walsh 1999).  
Several models have been proposed for AMP membrane permeability: the barrel-stave, toroidal 
pore, and carpet model (Shai 1999, Brogden 2005). When the concentration of peptide is low 
in relation to the lipids in the membrane, the peptides are orientated parallel to the lipid bilayer 
and can be functionally inactive. With increasing concentrations of peptide, they orientate 
perpendicularly and insert into the membrane. It is also possible that peptides adsorbed to the 
surface may translocate across the membrane without forming a pore (Sengupta et al. 2008). 
Models that successfully explain the pore structures may provide a better understanding of the 
activities of AMPs. 
 
2.3.1.1 Barrel-stave model 
This model was the first to explain peptide-induced pores and was proposed by Baumann & 
Mueller (1974). The model proposes that peptides insert into the membrane bilayer and 
aggregate, forming a cluster surrounding a central pore (Figure 2.3.1.1). The hydrophobic 
regions of the peptide align with the lipid bilayer and the hydrophilic regions interact with the 
lumen of the pore. Monomers bind to the membrane in an α-helical structure and recognise each 
other once bound to the membrane. After insertion, progressive recruitment of additional 
monomers occurs and increases the pore size (Shai 1999). The association of the helices with 
the membrane bilayer forms a barrel structure made up of staves surrounding a central lumen. 












Figure 2.3.1.1 Barrel-stave model (Image courtesy of M. Flynn. Adapted from Brogden 
2005). 
 
2.3.1.2 Toroidal pore model 
This model differs from the barrel-stave model in that the peptides interact with the lipid 
headgroups, even when inserted perpendicularly (Yang et al. 2001). The lipid heads bend 
continuously and merge in a toroidal manner to make a pore that is lined by the peptides and 
lipid headgroups (Figure 2.3.1.2). The polar ends of the peptide monomers associate with the 
polar lipid headgroups (Yamaguchi et al. 2002). Examples of AMPs which have been shown 
to induce toroidal-shaped pores include magainins (Matsuzaki et al. 1996, 1998), protegrins 
which are found in porcine leukocytes (Nguyen et al. 2011), and melittins, the major active 
component of bee venom (Yang et al. 2001). 
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In molecular dynamics simulations, the disordered toroidal pore model has also been observed 
whereby only a few peptides have been found near the pore centre while others remain close to 
the edge (Leontiadou et al. 2006, Sengupta et al. 2008). This model, however, has only been 
























2.3.1.3 Carpet model 
This model was first described by Pouny et al. (1992) to explain the mechanism of action of 
dermaseptin, an AMP produced in the skin of frogs. It involves the binding and aggregation of 
peptides parallel to the lipid bilayer with localised ‘carpeting’ of the membrane. Peptides are 
















Figure 2.3.1.3 Carpet model (Image courtesy of M. Flynn. Adapted from Brogden 2005). 
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Permeation of the membrane only occurs above the threshold concentration of the peptide. High 
concentrations of peptide on the membrane surface occurs in one of two ways: the membrane 
is either covered in peptide monomers or there is a direct association between the peptides. 
Above this threshold concentration, micelles are formed and pieces of the membrane separate 
(Figure 2.3.1.3). It is at this stage that a transient pore is formed. This is followed by complete 
membrane lysis. In this model, peptides do not necessarily need to adopt a specific structure 
(Shai 1999).  
 
2.3.2 Relevance of AMPs to dentistry 
The susceptibility of cariogenic and periodontal pathogens to a few AMPs has been studied. 
Antimicrobial agents such as histatin, lactoferrin, and lysozyme are produced in the oral cavity 
by epithelial cells and within the saliva, providing a first line of defence against opportunistic 
pathogens. Gingival epithelial cells present at the base of periodontal pockets have been 
reported to produce human β-defensins. Some of these AMPs have been shown to be effective 
against oral bacteria such as S. mutans (Nishimura et al. 2004), P. gingivalis, and F. nucleatum, 
but antibacterial activity was found to vary with the different strains and species depending on 
the net charge of the bacteria and the bacterial cell wall structure (Ouhara et al. 2005). 
Dommisch et al. (2005) demonstrated the expression of human β-defensin 1 and 2 by 
odontoblasts, possibly reflecting the role these cells play in the innate host defence of the dental 
pulp. 
Antimicrobial activity is of particular interest to the field of endodontics because the oral cavity 
is regularly colonised by a diverse range of microorganisms which can become opportunistic 
and because of the contribution of these microbes in the aetiology of pulp and periapical disease 
(Kakehashi et al. 1965). Commonly used intraradicular medicaments are non-specific 
antimicrobial compounds with varying degrees of host toxicity. There is a need for an 
intraradicular medicament which is able to effectively kill bacteria within the root canal system 
and which is well-tolerated by host tissues. AMPs appear to be promising therapeutic agents 
that can effectively reduce bacterial loads. There is, however, limited literature on their use in 
endodontics. Turner et al. (2004) assessed the ex vivo efficacy of the naturally occurring AMP, 
nisin, against E. faecalis and S. gordonii cells in solution and within the root canal system. Nisin 
is a class I bacteriocin produced by strains of Lactococcus lactis. It was found to be microbicidal 




Several AMPs have been developed and tested as their properties make them attractive 
candidates to combat infections and they offer several advantages over currently used 
therapeutics. Side-chain and/or backbone modifications to existing AMPs have been carried out 
to produce variants with enhanced microbicidal activities that overcome problems associated 
with natural peptides such as duration of activity, poor bioavailability, and susceptibility to 
proteolytic degradation. These modified peptides mimic natural peptides by interacting with 
the cell membrane and producing improved biological effects (Vagner et al. 2008).  One such 
approach is peptide D-enantiomerisation (Zhao & Lu 2011). Amino acids can occur in two 
isomeric forms: L- and D- forms, according to the configuration around the alpha carbon atom 
in the amino acid. L-amino acids occur naturally and are susceptible to degradation by 
proteases. D-amino acids are mirror images of L-amino acids, rarely occur naturally, are 
resistant to proteolytic degradation (Wade et al. 1990) and are less immunogenic. D-peptide 
drugs should consequently exhibit significantly improved stability (Wade et al. 1990). 
 
2.3.3 BM2 
A drug discovery strategy was developed by Monk and colleagues to inhibit the essential fungal 
enzyme, the plasma membrane proton pumping ATPase (Pma1p), required for fungal energy 
transduction (Monk et al. 2005). A combinatorial library comprising 1.8 million D-octapeptides 
was constructed and screened for inhibitors of the fungal species Saccharomyces cerevisiae and 
C. albicans by using Pma1p as the target. This identified the peptide, BM0 (D-NH2-
RFWWFRRR-CONH2). Optimisation of BM0 led to the synthesis of the D-decapeptide, BM2 
(D-NH2-RRRFWWFRRR-CONH2) which was found to possess broad-spectrum fungicidal 
activity. BM2 is composed of a triarginine motif and a core of phenylalanine and tryptophan 
with amidation of the C-terminus. 
Peptides rich in arginine and tryptophan have been shown to possess broad and potent 
antimicrobial activity (Vogel et al. 2002, Chan et al. 2006). Tryptophan residues have a 
preference for the interfacial region of lipid bilayers (Yau et al. 1998) while arginine residues 
provide the peptides with cationic charges and hydrogen bonding properties necessary for 
interaction with the abundant anionic components of bacterial cell membranes (Chan et al. 
2006). Arginine and tryptophan make the peptides highly active even at very short peptide 
lengths, such as with BM2.   
Preliminary in vitro studies found BM2 inhibits the growth of the common endodontic 
pathogens S. mutans, S. gordonii, and C. albicans in their planktonic state and against 
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monospecies biofilms, including E. faecalis which is frequently isolated in refractory disease 
(Yoganathan 2012, Othman 2014). It showed microbicidal activity at concentrations 
significantly lower than the currently used endodontic irrigant, sodium hypochlorite and 
antimicrobial effects that were comparable to saturated calcium hydroxide. Sodium 
hypochlorite was more effective at E. faecalis biofilm detachment compared to aqueous BM2 
using the crystal violet biofilm assay, however, concentrations several hundred-fold higher 
were required. Assessment of E. faecalis biofilms using confocal laser scanning microscopy 
(CLSM) revealed almost complete loss of cell viability with BM2 at a concentration of 160 
µg/mL. Only a slight reduction in biofilm height was observed with limited cell detachment 
using the crystal violet biofilm assay (Yoganathan 2012). Othman (2014) showed, using the 
crystal violet biofilm assay and CLSM assessment, that aqueous BM2 at 20 µg/mL significantly 
reduced the thickness of C. albicans biofilms with total viable cells comprising only 10% after 
exposure for 72 hours. BM2 at 40 µg/mL almost completely eliminated S. gordonii and S. 
mutans biofilms with viable cells of the remaining biomass comprising 25% and 10% 
respectively. E. faecalis biofilms subjected to aqueous BM2 at 40 µg/mL were significantly 
reduced after 72 hours with viable cells comprising 40% of the remaining biomass. The in vitro 
antimicrobial potential of BM2 was highlighted in both studies, however, the clinical efficacy 
within the complex root canal system and penetration into the radicular dentinal tubules still 
needs to be investigated.  
Treatment of infections in poorly vascularised sites remains difficult with conventional 
systemic antibiotic therapy. Systemic therapy has the potential for adverse effects and is 
ineffective in endodontics due to the lack of vascularisation in pulpless or necrotic teeth. 
Consequently, systemic antimicrobials are not favoured in the management of root canal 
infections. The local application of intracanal therapeutic agents is likely to be a more effective 
method to achieve controlled and sustained release with broad-spectrum antimicrobial activity 
and low systemic side effects. The antimicrobial efficacy of currently used irrigants and 
medicaments is well established, however, they have the potential to be cytotoxic by causing 
local tissue irritation or hypersensitivity. An endodontic medicament able to effectively kill 
therapy-resistant bacteria within root canals and radicular dentine with minimal or no host 





The ideal matrix for local delivery of antimicrobials should provide sufficient drug carriage, 
good tolerability by host tissues, be biodegradable, and sustain a controlled release over time 
(Veyries et al. 1999). 
Hydrogels are crosslinked polymers which possess the ability to swell in an aqueous medium. 
Crosslinking occurs by either chemical or physical means, depending on the properties of the 
polymer as well as the experimental conditions. Physical gels are crosslinked via processes such 
as hydrophobic association, chain aggregation, crystallisation, ion-polymer or polymer-
polymer complexation, or hydrogen bonding. These gels are reversible. In contrast, chemical 
gels are prepared via chemical covalent crosslinking and are irreversible (Omidian & Park 
2012). In their swollen state, hydrogels exhibit excellent water affinity, high thermal and 
mechanical stability and biocompatibility which makes them of great interest in the fields of 
medicine, pharmaceuticals and dentistry (Hoffman 2012). 
In situ polymer gel-forming systems prolong the residence time of drugs and improve 
bioavailability. They were introduced in the early 1950s and have been used as food additives, 
detergent formulations, in cosmetics, and for a diverse range of pharmaceutical applications 
(Veyries et al. 1999). Within the pharmaceutical industry, they have been used as defoaming 
and foaming agents, detergents, dispersing agents, emulsifying agents, gelling agents and 
solubilising agents (Garcia Sagrado et al. 1994). They are water-soluble, stable, non-toxic, and 
inert surfactants.  
These polymer-based gels involve a reversible phase transition from solution to gel in response 
to changes in temperature or pH. Thermoresponsive hydrogels undergo transitions upon heating 
or cooling due to changes in intermolecular interactions (Chen et al. 2013). These gels are 
soluble in water at low temperatures and become insoluble when temperature rises and involves 
a change from hydrogen bonding to hydrophobic interactions (Omidian & Park 2012). 
Examples include poly(N-isopropyl acryl-amide), cellulose derivatives, and polyoxyethylene-
polyoxypropylene-polyoxyethylene polymers. Polymers sensitive to pH changes include those 
containing carboxyl or amino groups. Ionisation and hydration changes depending on the pH 
of the medium (Omidian & Park 2012). Polymer gels involving phase transitions in response 
to pH changes may take a longer time to form a gel when administered into a root canal system 
due to the lack of an appropriate pH gradient. The faster the gel transformation occurs, the 
smaller the risk of the gel being diluted with physiological fluid at the site of application 
(Charrueau et al. 2001, Kojarunchitt et al. 2011). A longer setting time of the polymer gel could 
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Polyoxypropylene core Polyoxyethylene block Polyoxyethylene block 
result in dose dumping, an undesired side effect. This has been defined as unintended and rapid 
drug release in a short period of time of the entire amount or a significant fraction  of the drug 
contained in a modified release dosage form (Meyer & Hussain 2005). The use of a 
thermoresponsive gel for administration of a drug into the root canal system may provide a 
more apt and precise method for drug delivery than pH responsive gels.  
One widely studied class of thermoresponsive polymer gels are the poloxamers, also known as 
pluronics. These copolymers are composed of a central hydrophobic core of polyoxypropylene 
(PPO) surrounded by hydrophilic blocks of polyoxyethylene (PEO) to produce a triblock 
structure as shown in Figure 2.4 (Dumortier et al. 2006).  They are synthesised by sequential 
anionic polymerisation of PPO and PEO monomers in the presence of sodium or potassium 
hydroxide (Schmolka 1977, Kabanov et al. 2002). Different ratios of the hydrophobic and 
hydrophilic components can be used to produce polymers of different molecular weights with 






Figure 2.4 Structure of polymer gels. 
The unique property of thermogelation permits dispersion of a drug within a medium able to be 
administered by syringe as a solution that forms a semi-solid gel at physiological temperatures. 
As the sol-gel transition temperature is reached, the viscosity increases by virtue of the 
formation of micelles which aggregate. Below this temperature, they remain fluid. These gels 
possess the ability to be reversed back to a fluid state at lower temperatures without alteration 
of their properties (Schmolka 1972). 
Poloxamers are free-flowing injectable solutions which should be advantageous for 
administration into a root canal system. One such example is Poloxamer 407. Its unique 
thermoreversible gelation properties have made it one of the most extensively studied 
poloxamer gels. These gels are expected to transform into a gel shortly after administration into 
the root canal system due to their superior thermoresponsive behaviour at body temperature. 
They have been shown to form strong gels which are efficient in the slow release of active 
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components (Bhardwaj & Blanchard 1996). Furthermore, these gels are readily available on the 
market and are economical.  
 
2.4.1 Poloxamer 407 
Poloxamer 407 (P407 or Pluronic® F127) gels are non-toxic colourless gels, consisting of 70% 
PEO and 30% PPO and have a molecular weight of approximately 12,600 as determined by 
mass spectrometry (Takáts et al. 2001). The ratio of PEO to PPO is approximately 2:1 
(Schmolka 1972) where the values of a and b, as in Figure 2.4, are 101 and 56, respectively 
(Takáts et al. 2001).  
P407 aqueous solution exists as a free-flowing liquid at temperatures around 5-10°C and forms 
a semi-solid solution when the temperature is increased to ambient temperatures, around 24-
25°C, depending on the concentration of the polymer used. When the solution is brought to 
physiological temperatures at around 37°C, it forms a gel (Johnston & Miller 1985).  
P407, an amphiphilic block copolymer, self-assembles in water to form micelles due to 
dehydration of the PPO hydrophobic core, producing a spherical structure (Chen-Chow & 
Frank 1981, Juhasz et al. 1989). These micelles possess a dehydrated core with an outer 
structure of swollen chains (Cabana et al. 1997, Moore et al. 2000). The aggregation of micelles 
at higher temperatures is driven by the hydrophobic interactions between the dehydrated PPO 
blocks which results in gelation as shown in Figure 2.4.1. Apart from aggregated micelles, P407 
gels also consist of aqueous channels in which the incorporated drug may be released into. 




One of the limitations of P407 is its low mechanical strength and limited micellar stability in 
aqueous environments, resulting in erosion (Kojarunchitt et al. 2011). This occurs due to 
dilution of P407 copolymers upon contact with excess solvent leading to a drop below the 
critical gelation concentration (Chun et al. 2005). 
P407 can be used at different concentrations, depending on the desired viscosity. It has been 
reported that different types of crystalline structures are produced depending on the 
concentration. At concentrations ranging from 20-40% w/v, a face centred cubic structure is 
obtained. At higher concentrations, such as 50% w/v, a body centred cubic packing of micelles 
is seen (Liu & Chu 2000). This configuration is shown in Figure 2.4.2.  
 
Figure 2.4.2 Crystalline structures produced with the varying concentrations of P407 (Image 
courtesy of M. Flynn). 
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This results in a higher viscosity, greater level of rigidity and slow dissolution of the gel. This 
occurs due to a shorter intermicellar distance with increased cross-linking between micelles and 
a greater number of micelles per unit volume (Bhardwaj & Blanchard 1996). Furthermore, it 
has been reported that increasing the polymer concentration results in a decreased sol-gel 
transition temperature (Ricci et al. 2002) as the degree of micellar swelling and aggregation 
needed to form a network is smaller.  
P407 gels have been used for transdermal, injectable and ocular applications (Miller & Donovan 
1982, Miyazaki et al. 1995, Paavola et al. 1998). Actives such as drugs and vaccines can be 
incorporated into the gels by simply mixing with the temperature-sensitive polymer solution at 
lower temperatures (Bobbala et al. 2016). P407 is the most commonly used gel-forming 
polymer matrix to deliver proteins (Morikawa et al. 1987, Juhasz et al. 1989, Gombotz & Pettit 
1995). However, literature on the use of Poloxamers in dentistry and more specifically, 
endodontics, is lacking. Within dentistry, Poloxamers have been tested as dentifrice surfactants 
(Zinner et al. 1977, Ong & Strahan 1989), formulations for direct intrapocket administration 
for the treatment of periodontitis (Medlicott et al. 1994, Esposito et al. 1996, Garala et al. 2013) 
and as thickening agents in bleaching systems (Soldani et al. 2010). To date, only one paper 
has reported on the use of Poloxamer in a root canal model. P407 was used as a vehicle for 
delivery of Artocarpus lakoocha extract, a tropical tree species commonly found in India and 
Thailand (Teanpaisan et al. 2013). The authors found administration of A. lakoocha extract in 
a P407 carrier had superior antimicrobial properties to calcium hydroxide paste against E. 
faecalis.  
Poloxamer 407 will be used for the present study as it has been reported to be biocompatible, 
stable, the most non-toxic of the poloxamer gels and possess weak immunogenic properties 
(Ricci et al. 2002). It is expected to provide a novel drug delivery system which will allow 
controlled and sustained release over a given period of time. Incorporation of BM2 into this 
gel-forming system may provide a suitable medium to deliver BM2 into the root canal system 
and for subsequent sustained release from the matrix it forms. Studies of the rheological 
characteristics are needed as this will determine the rate of gel dissolution and rate of release of 
drug from the gel. Determination of the stability of P407 with and without the incorporation of 
BM2 is needed to assess whether BM2 impacts on the stability and in addition to this, measure 




2.4.2 In vitro stability testing 
It is essential to investigate the behaviour of the formulations through in vitro stability testing 
of the gel with and without inclusion of the drug. Poloxamer dissolution involves the hydration 
of water-insoluble side groups that are converted to water-soluble polymers as a result of 
ionisation, protonation, or hydrolysis of the groups (Gombotz & Pettit 1995). A dissolution 
profile can be obtained through measurement of change in polymer weight over time with the 
use of a release medium (Bobbala et al. 2016).  
 
2.4.3 In vitro release studies 
Several studies have assessed the rheological properties of polymer gels and their in vitro 
release characteristics (Chen-Chow & Frank 1981, Veyries et al. 1999, Moore et al. 2000). 
Release of the active drug is controlled by the surface hydration rate. The more lipophilic the 
drug, the more it becomes incorporated within the micelles due to more hydrophobic 
interactions with the PPO core, with less present in the aqueous channels to be released.  
Increasing concentrations of P407 may be associated with a reduced rate of release which is 
attributed to the higher degree of micellar aggregation resulting in a stronger gel. This results 
in a greater tortuosity in the aqueous phase of the gel structure and a resultant slower dissolution 
rate (Gilbert et al. 1986, Zhang et al. 2002).  
 
2.5 In vitro testing 
2.5.1 Confirmation of bacterial strains 
The use of 16S ribosomal RNA (rRNA) gene sequencing is a well-established and common 
method to study bacterial phylogeny and taxonomy as it provides species-specific sequences 
which are useful for bacterial identification. The technique was pioneered by Woese and Fox 
(1977) who established that phylogenetic relationships of bacteria could be determined by 
comparing a stable part of the genetic code. This included the genes that code for the 5S, 16S, 
and 23S rRNA, the most commonly used being the 16S rRNA gene. The sequences are used as 
a genetic marker as the 16S rRNA gene is critical for cell function and is present in most 
microbes. It has played a pivotal role in the accurate identification of strains and the discovery 
of novel bacteria in clinical microbiology (Woo et al. 2008). Using this technique, numerous 
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bacterial genera have been reclassified and renamed, classification of uncultivable bacteria has 
been made possible, and phylogenetic relationships have been determined. 
The 16S rRNA gene sequence has been determined for a large number of strains and deposited 
in several databases. GenBank® is one of the largest databases of nucleotide sequences with 
over 20 million entries. These databases can be used to compare sequences of unknown strains 
(Clarridge 2004).  
The steps involved in identification of bacterial species includes extraction of DNA, 
amplification of the 16S rRNA genes by PCR, purification, sequencing and finally, comparison 
with the GenBank® database (Kolbert & Persing 1999). 
 
2.5.2 Planktonic cells 
2.5.2.1 Minimum inhibitory concentration 
The minimum inhibitory concentration (MIC) of an antimicrobial has been defined as the 
lowest concentration able to inhibit the visible growth of a microorganism after a defined 
incubation period (Andrews 2001), as determined by turbidity. MICs have been considered the 
gold standard for determining the susceptibility of microorganisms and have been used as a 
diagnostic laboratory tool for assessing the in vitro activity of new antimicrobials (Turnidge 
2015).  
Typically, two techniques are utilised in the laboratory to determine MIC: agar and broth 
dilution methods (Weigand et al. 2008). A stock solution of the antimicrobial of known 
concentration is prepared with serial 2-fold dilutions to produce a range of concentrations. The 
microbial suspension is grown as a pure culture and the optical density adjusted to a density 
comparable to a McFarland turbidity 0.5 standard (McFarland 1907). Knowing the cell number 
in the final inoculum is of critical importance for obtaining accurate and reproducible results, 
the recommendation being 5 x 105 colony forming units (CFU)/mL (Weigand et al. 2008). Agar 
dilution involves the use of a nutrient agar medium with the different antimicrobial 
concentrations incorporated onto which the microbial inoculum is then placed. Broth dilution, 
on the other hand, is carried out in a microtitre plate using liquid medium (Weigand et al. 2008). 
The MIC can be determined after exposing the microbial inoculum to the range of antimicrobial 
concentrations and incubation. The broth microdilution assay, recommended by the Clinical 
and Laboratory Standards Institute (CLSI) (2008), allows the use of smaller quantities of test 
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antimicrobial and growth medium and is consequently the technique employed in this research 
(Griffin et al. 2000). 
The limitation with the use of MICs is that current techniques are semi-quantitative and give an 
approximation of the lowest concentration. Consequently, values should be used as an indicator 
of activity rather than as a substantive value (Lambert & Pearson 2000). Furthermore, it does 
not give an indication of the mode of action, that is, whether the agent is static or cidal. Further 
testing needs to be conducted on the lowest concentration to establish the exact mode of action. 
This is described in further detail in the next section. 
  
2.5.2.2 Minimum bactericidal/fungicidal concentration 
The minimum bactericidal concentration (MBC) or minimum fungicidal concentration (MFC) 
is the lowest concentration of the antimicrobial able to prevent complete growth and kill a 
microorganism after incubation and subculturing onto appropriate medium (Andrews 2001). 
The MBC/MFC can be established by subculturing the broth dilution from the microtitre plate 
onto appropriate nutrient agar and checking for the absence of growth (Mah 2014) .  
Cationic peptides have been reported to be bactericidal with the MBC and MIC coinciding or 
differing by no more than 2-fold (Hancock 2001). The mechanism of action owing to their 
bactericidal activity has been attributed to interaction with the cytoplasmic membrane, 
however, this mechanism of action is yet to be confirmed for the peptide, BM2. Previous 
research found BM2 to exhibit microbicidal activity in solution against certain endodontic 
pathogens (Yoganathan 2012, Othman 2014). The efficacy of this peptide incorporated into a 
gel medium has not been tested and it is unknown whether it will demonstrate comparative 




2.5.3.1 Crystal violet assay 
Crystal violet, also previously termed gentian violet, is a basic dye which stains the nuclei of 
cells by binding externally to the DNA. It also binds to negatively charged surface molecules 
and polysaccharides in the extracellular matrix (Li et al. 2003, Peeters et al. 2008). The 
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irreversible fixation of this dye by gram-positive bacteria is the basis of the Gram-stain 
(Docampo & Moreno 1990).  
The microtitre plate biofilm formation assay is used to study the early stages in biofilm 
formation and has been utilised in the study of predominantly bacterial biofilms but also to a 
lesser extent fungal biofilms (O’Toole 2011). 
The crystal violet assay can be used to obtain quantitative information regarding the density of 
cells adhering to the wells of a microtitre plate (Stepanovic et al. 2000). The cells are stained 
with the dye and any excess dye and unstained cells are washed off. Quantification can be 
carried out by solubilising the absorbed dye and determining the optical density using 
spectrophotometry (Gillies et al. 1986). The technique has been shown to be a reliable and 
reproducible method demonstrating a linear relationship between absorbance, measured as 
optical density, and cell number (Gillies et al. 1986, Saotome et al. 1989). 
The limitation with the use of crystal violet staining is that it stains the entire biofilm biomass 
including cells and extracellular polysaccharide matrix. This is not limited to viable cells but 





Preliminary in vitro studies have found the stable cationic AMP, BM2, to be an effective AMP 
against certain planktonic endodontic pathogens and monospecies biofilms when tested in the 
form of a solution. The antimicrobial efficacy of BM2 in an injectable gel matrix needs to be 
investigated.  
The aims of this research are: 
1) To develop a sustained release delivery system suitable for the intracanal delivery of 
BM2 which is stable in vitro. 
2) To evaluate the in vitro release of BM2 from P407 gel. 
3) To assess the susceptibility of certain species of the endodontic microflora to BM2 in a 
gel medium. 
4) To assess the antimicrobial effect of BM2 in a gel medium on monospecies biofilms by 
comparison with the currently used intraradicular medicament, calcium hydroxide. 
 
2.7 Hypotheses 
The following hypotheses will be tested: 
1) BM2 incorporated into a P407 matrix will be stable and suitable as an intracanal 
delivery system. 
2) BM2 will be released over a clinically effective period of time from P407. 
3) The species tested will be susceptible to BM2-loaded P407 gels in planktonic cultures. 
4) BM2-loaded P407 gels will demonstrate antimicrobial activity against monospecies 
biofilms.  





Chapter 3:   Materials and methods 
3.1 Selection of microbes 
All microorganisms used in this study were sourced from the Molecular Biosciences Laboratory 
Culture Collection (School of Dentistry, University of Otago, NZ). Strains representing species 
of microorganisms frequently isolated from an infected root canal system were chosen, namely 
Streptococcus mutans NG8, Streptococcus gordonii DL1 (also known as strain Challis), 
Enterococcus faecalis JH2-2 and Candida albicans ATCC 10261. Strains were obtained from 
frozen 15% (vol/vol) glycerol stocks stored at -80ºC. These strains and their general 
characteristics are shown in Table 3.1. The stocks were thawed and a loop of stock was streaked 
onto appropriate agar plates using an aseptic technique. Bacterial strains were initially streaked 
onto brain heart yeast infusion (BHY) agar (Difco Laboratories, Detroit, MI, USA) plates then 
subcultured onto Columbia sheep blood agar (CBA) (Fort Richard Laboratories, Auckland, NZ) 
plates, mitis salivarius agar (Fort Richard Laboratories) plates, and mutans selective media 
(MSM) (Fort Richard Laboratories). All bacteria were cultivated at 37ºC for 48 h under 
anaerobic conditions in a Gas-Pak™ EZ Gas Generating Container System (Becton, Dickinson 
and Co., Sparks Maryland, USA). C. albicans were routinely subcultured onto yeast extract 
peptone dextrose (YPD) agar (Difco Laboratories) plates and incubated at 30oC aerobically.  
Table 3.1 Microorganism panel. 
 
  
Strain Gram stain Growth conditions Role in endodontics 
Streptococcus mutans NG8 Positive Facultative anaerobe Initiation of primary infection 
Streptococcus gordonii DL1 Positive Facultative anaerobe Initiation of primary infection 
Enterococcus faecalis JH2-2 Positive Facultative anaerobe Refractory infection 
Candida albicans ATCC 10261 Positive Aerobe Refractory infection 
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3.2 Selection and preparation of growth media 
3.2.1 Agar plates 
Brain heart infusion agar 
Brain heart yeast infusion (BHY) agar (brain heart infusion 37 g/L, yeast extract 5 g/L, and 
bacteriological agar 15 g/L, Difco Laboratories) is a non-selective medium used for the 
cultivation of a wide variety of fastidious microorganisms including streptococcal species. The 
brain heart infusion, peptone and dextrose components provide the nutrients for BHY agar. 
A solution was prepared by dissolving the respective components in 1 L of distilled water and 
was stirred using a magnetic stirrer. The solution was autoclaved at 121ºC in a high pressure 
steam autoclave (Tomy Seiko Co., Ltd, Tokyo, Japan) for 20 min, allowed to cool, and poured 
into petri dishes. Plates were left to set overnight and then stored at 2-4ºC until required. 
 
Columbia sheep blood agar 
Columbia blood agar with sheep blood medium (CBA) (Fort Richard Laboratories) is used for 
the isolation and cultivation of a wide variety of fastidious microorganisms. It was first 
developed by Ellner et al. (1966). Sheep red blood cells provide the heme needed for detection 
of haemolysis and allows differentiation between alpha and beta haemolytic species. Alpha-
haemolytic Streptococcus spp. such as S. mutans or S. gordonii oxidise the iron in haemoglobin 
producing a greenish colour on blood agar. Beta-haemolytic species, such as E. faecalis cause 
complete lysis of red blood cells, producing a translucent zone clear of blood cells surrounding 
colonies. CBA was used to differentiate between S. mutans, S. gordonii, and E. faecalis through 
pigment production. 
 
Mitis salivarius agar 
Mitis salivarius agar (Fort Richard Laboratories) medium is used for selective isolation of 
certain species of streptococci and enterococci. The inclusion of crystal violet dye and 1% 
potassium tellurite inhibits the growth of most gram-negative bacilli and gram-positive bacteria 
except streptococcal and enterococcal species. The trypan blue is absorbed by Streptococcus 
colonies, producing a blue colour. 
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Mitis salivarius agar was used to differentiate between S. mutans and E. faecalis through the 
characteristic appearance of colonies. E. faecalis produces blue-black colonies whilst S. mutans 
produces blue colonies with a frosted appearance.  
 
Mutans selective agar 
Mutans selective medium (Fort Richard Laboratories) was developed for the isolation of S. 
mutans and is a modification of Mitis salivarius agar containing 0.2 units/mL bacitracin with 
an increase in the sucrose concentration to 20% (Gold et al. 1973, Emilson & Bratthall 1976). 
This optimal concentration of sucrose and bacitracin allows maximum inhibition of other 
streptococci without inhibition of S. mutans. 
 
Yeast extract peptone dextrose agar 
Yeast extract peptone dextrose (YPD) agar (yeast extract 10 g/L, bacteriological peptone 20 
g/L, glucose 20 g/L, and bacteriological agar 15 g/L, Difco Laboratories) is used for 
maintaining and propagating yeast. 
A solution was prepared by dissolving the respective components in 1 L of distilled water and 
was stirred using a magnetic stirrer. The solution was autoclaved at 121ºC (Tomy Seiko Co., 
Ltd) for 20 min, allowed to cool, and poured into petri dishes. Plates were left to set overnight 
and then stored at 2-4ºC until required. 
 
CHROMagar™ 
CHROMagar™ Candida (peptone 10.2 g/L, chloramphenicol 0.5 g/L, chromogenic mix 22 g/L 
and agar 15 g/L, Fort Richard Laboratories) is a selective chromogenic medium for isolating 
and differentiating yeasts and filamentous fungi by colour and morphology. The presence of 








Tryptic Soy Broth 
Tryptic soy broth (TSB) (Difco Laboratories) is an all-purpose liquid medium used for the 
enrichment and cultivation of a wide variety of microorganisms, especially for the preparation 
of inocula.  
TSB was prepared by dissolving 30 g in 1 L of distilled water, stirred with a magnetic stirrer. 
The solution was autoclaved at 121ºC (Tomy Seiko Co., Ltd) for 20 min, allowed to cool, and 
stored at room temperature until required.  
 
Synthetic Defined Medium 
Complete synthetic defined (SD) media is a mixture of amino acids, vitamins, and other 
essential components that together with yeast nitrogen base and glucose, supports the vigorous 
growth of yeast cells. SD medium contains yeast nitrogen base without amino acid 6.7 g/L, 
complete supplement mixture (CSM) 0.77 g/L and glucose 20 g/L. It is buffered with 10 mM 
MES buffer (2-(N-morpholino)ethanesulfonic acid) 1.95 g/L, 20 mM HEPES buffer (4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid) 4.77 g/L, TRIS (Tris(hydroxymethyl) 
aminomethane) 1.67 g/L. 
SD media was prepared by dissolving the respective components in 1 L of distilled water, stirred 
using a magnetic stirrer. The solution was autoclaved at 119ºC (Tomy Seiko Co., Ltd) for 17 
min, allowed to cool, and stored at room temperature until required. When required for use, the 
SD medium was adjusted to pH 6.8 by adding 1 M TRIS solution and filtered aseptically using 
a sterile 25 mm diameter 0.22 µm syringe filter (Millex®, Merck Millipore, Darmstadt, 
Germany) into a sterile 50 mL Falcon tube (Greiner Bio-One GmbH, Frickenhausen, Germany).  
 





3.3 Confirmation of species 
3.3.1 Bacterial species 
16S ribosomal RNA (rRNA) gene sequencing was used to confirm bacterial species prior to 
use. Isolates were identified by amplifying the 16S rRNA genes from selected colonies of each 
strain of interest followed by DNA sequencing using the Sanger method (Sanger et al. 1977). 
Single colonies of each isolate were obtained using a toothpick and resuspended in 50 μL of 
sterile deionised water (Molecular Biology Grade, 5 Prime, Germany). One microlitre of each 
cell suspension was then subjected to colony PCR experiments to amplify the 16S rRNA gene 
using primers IonTor-U8FP1 (5’- CTAAGGTAACAGAGTTTGATCMTGGCTCAG -3’) and 
IonTor-RP1 (5’- CTAAGGTAACCTGCTGCCTYCCGTA -3’). PCR was conducted in 50 μL 
reactions (in 0.2 mL PCR tubes) that contained the following components: 
Table 3.3.1 Components of PCR.  
10× DNA polymerase buffer B2 (detergent- and MgCl2-free) 5 μL 
10 mM dNTP mix (Roche, Germany)   1 μL 
50 mM MgCl2  2 µL 
Primer IonTor-U8FP1 (Life Technologies, Auckland)  1 µL 
Primer IonTor-RP1 (Life Technologies, Auckland) 1 µL 
HOT FIREPol DNA polymerase (Solis Biodyne, Estonia) 0.5 µL 
DNA template, i.e., cell suspension 1 μL 
Molecular biology grade water (5 Prime, Germany) 38.5 μL 
Total 50 μL 
 
The PCRs were carried out in an Eppendorf Mastercycler® Gradient apparatus (Eppendorf AG, 
Hamburg, Germany) using the following thermal cycling parameters:  
1) Initial denaturation at 95oC for 15 min 
2) 30 cycles of the following:  
a. Denaturation: 95oC for 30 sec 
b. Annealing: 55oC for 30 sec  
c. Elongation: 72oC for 20 sec  




Purification of the PCR products of the expected size (380 bp) was carried out using 
NucleoSpin® Gel and PCR Clean-up spin columns (Macharey-Nagel GmbH & Co., Germany) 
and the purified amplicons sent for Sanger sequencing  (Genetic Analysis Services, Department 
of Anatomy, University of Otago) (Sanger et al. 1977) as described in the following sections. 
 
PCR Clean-up Procedure 
One volume of the PCR product was mixed with two volumes of Buffer NTI in a NucleoSpin® 
column (Macharey-Nagel GmbH & Co.). The column was then placed in a 2 mL collection 
tube, centrifuged at 11,000 x g for 30 secs to bind the DNA and the flow-through discarded. 
The silica membrane with the bound DNA was washed twice: first by adding 700 μL of NT3 
buffer to the column, centrifuging at 11,000 x g for 30 secs and discarding the flow-through 
and then a second time by adding 700 μL of NT3 buffer to the column, centrifuging at 11,000 
x g for 1 min and discarding the flow-through to remove any remaining ethanol and dry the 
membrane. The NucleoSpin® column was placed in a sterile 1.5 mL microcentrifuge tube and 
30 μL of NE elution buffer was applied to the centre of the column. After incubation at room 
temperature for 1 min, the column was centrifuged at 11,000 x g for 1 min to elute the purified 
PCR amplicon DNA. 
  
PCR Quantification 
Quantification and purity of all DNA samples was determined by absorption spectrophotometry 
using a NanoVue™ spectrophotometer (GE Healthcare Life Sciences, U.K.) and NucleoSpin® 
elution buffer as a blank. The amount of DNA present in each sample was determined by 
measuring the absorbance at 260 nm (A260). The purity of the DNA sample was estimated from 
the A260 (nucleic acid) /A280 (protein) ratio. A ratio of 1.8-1.9 was obtained for all samples, 
indicating a high purity level. 
 
Agarose gel electrophoresis 
The quality and quantity of the purified PCR products was analysed by agarose gel 
electrophoresis (Green & Sambrook 2012). The concentration of agarose used was 1.0% (w/v). 
The gels were run in Tris-acetate-EDTA buffer (40 mM Tris-HCl, 1 mM EDTA, 20 mM acetic 
acid) (Green & Sambrook 2012). Five microlitres of each DNA sample was mixed with 1 µL 
of 6× loading dye (30% (w/v) glycerol, 0.1% bromophenol blue and 0.001% xylene cyanol) 
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prior to loading (Green & Sambrook 2012). Gels were run at 100 volts for 45 min. The gels 
were stained with ethidium bromide (5 µg/mL) and visualised under ultraviolet (UV) 
transillumination with a Gel Doc™ EZ Imager (Bio-Rad Laboratories, USA). Gel images were 
captured by using Image Lab™ version 3.0 (Bio-Rad Laboratories). 
  
Sequencing of colony-derived PCR amplicons 
Purified amplicons (10 ng of each sample) derived from colony PCRs were sequenced by 
Genetic Analysis Services (Department of Anatomy, University of Otago) using conventional 
Sanger chemistry with a 3730XL DNA Analyzer (Applied Biosystems, USA). The sequencing 
primer used was primer IonTor-U8FP1. Each DNA sequence was visualised and any basecall 
errors edited with FinchTV version 1.4 (Geospiza Inc., U.S.A.). Species identification of each 
16S rRNA sequence was then accomplished using the BLASTN algorithm (Altschul et al. 
1997) to query the GenBank® DNA database for identical or very similar entries. 
 
All species were confirmed as is described in Table 3.1. 
 
3.3.2 Fungal species 
Single colonies were aseptically removed from the previously inoculated YPD agar plates and 
routinely subcultured onto CHROMagar™ plates (Fort Richard Laboratories). The presence of 
green colonies confirmed the strain to be C. albicans.  
 
3.4 Preparation of glycerol stocks 
Single colonies of S. mutans NG8, S. gordonii DL1, and E. faecalis JH2-2 were removed from 
each previously streaked CBA plate, resuspended in 10 mL TSB in 20 mL glass universal bottle 
and incubated at 37°C without shaking for 24 h. The broth was harvested by centrifugation 
(11,500 x g for 8 min) and the pellet resuspended in 5 mL TSB containing 15% (vol/vol) 
glycerol using a vortex mixer. The bacterial glycerol stocks were stored as 1 mL samples in 1.5 
mL sterile tubes (Raylab, Glendene, Auckland, NZ) at -80°C until required.  
A single colony of C. albicans ATCC 10261 (American Type Culture Collection, Manassas, 
VS, USA) was removed from the previously streaked YPD agar plate, resuspended in 10 mL 
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YPD broth in a 20 mL glass universal bottle and incubated at 30°C with shaking for 24 h. The 
broth was harvested by centrifugation (11,500 x g for 8 min) and the pellet resuspended in 5 
mL YPD broth containing 15% (vol/vol) glycerol. The C. albicans ATCC 10261 glycerol stock 
was stored as a 1 mL sample in a 1.5 mL sterile tube (Raylab) at -80°C until required. 
 
3.5 Preparation of inocula 
3.5.1 Bacterial inoculums 
Suspensions of S. mutans NG8, S. gordonii DL1, and E. faecalis JH2-2 were streaked onto 
BHY agar (Difco Laboratories) plates and incubated at 37°C for 48 h under anaerobic 
conditions to obtain isolated colonies. Two or three colonies were transferred aseptically into 3 
mL sterile TSB and incubated for 16 h. The overnight microbial suspension was adjusted to an 
optical density at 600 nm (OD600nm) of 0.5. This contained approximately 5 x 10
8 colony 
forming units (CFU)/mL. The starting inoculum was obtained by adding 200 µL to 19.8 mL of 
TSB to dilute the culture 1:100, giving approximately 5 x 106 CFU/mL. 
 
3.5.2 Fungal inoculums 
A suspension of C. albicans ATCC 10261 was streaked onto a YPD agar plate and incubated 
at 30°C for 48 h aerobically to obtain isolated colonies. Two or three colonies were transferred 
aseptically into 3 mL sterile, pH-adjusted SD medium and incubated for 16 h.  The overnight 
fungal suspension was adjusted to an OD600nm of 0.5. This contained approximately 10
7 
CFU/mL. The starting inoculum was obtained by adding 200 µL to 19.8 mL of SD medium to 
dilute the culture 1:100, giving approximately 105 CFU/mL. 
 
3.6 Preparation of antimicrobial solutions 
3.6.1 Preparation of BM2 
The D-decameric peptide BM2 (sequence: D-NH2-RRRFWWFRRR-CONH2) synthesised by 
GenScript® (Piscataway, New Jersey, USA) at a purity estimated by high performance liquid 
chromatography to be 95-99%, was stored at -20°C.   
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Three hundred milligrams of the peptide was solubilised in 9.25 mL of sterile deionised water, 
as recommended by the manufacturer, to give an estimated concentration of 20 mM. The 
peptide solution was stored as 1 mL aliquots at -20°C until required.  
 
3.6.1.1 Determination of the net peptide amount 
Two microlitres of the thawed peptide solution was pipetted into the first well of a 96 well 
microtitre plate (Greiner Bio-One GmbH) together with 198 µL phosphate buffer saline (PBS). 
Serial 2-fold dilutions were carried out to produce samples in the range 3.125 – 200 µM (See 
Appendix A). Samples were transferred to plastic cuvettes suitable for UV measurements and 
subjected to spectrophotometric analysis to determine their absorbance at 280 nm, with PBS 
serving as a blank. A molar extinction coefficient of 11,500 M-1cm-1 (Ɛ280nm = 11,500 M
-1cm-1) 
was used to calculate the theoretical concentration of the BM2. 
The theoretical values equated to twice the experimental absorbance indicating an overall 
concentration of 10 mM. 
 
3.6.2 Preparation of calcium hydroxide 
A saturated solution of calcium hydroxide (Ca(OH)₂) (Sigma-Aldrich®, St. Louis, MO, USA) 
was prepared by mixing 16 mg of Ca(OH)₂ powder with 10 mL of sterile distilled water. The 
mixture was centrifuged at 3000 RPM (1077 x g) for 15 min to clarify the solution. The aqueous 
supernatant layer was filtered aseptically using a sterile 25 mm diameter 0.22 µm syringe filter 
(Millex®, Merck Millipore) into a sterile 15 mL falcon tube (Greiner Bio-One GmbH). The pH 
of the saturated solution was determined using a pH meter to be 12. The saturated Ca(OH)₂ 
solution was prepared as required for subsequent experiments.  
 
3.6.3 Preparation of polymer gel 
Poloxamer 407 (P407) (Sigma-Aldrich®) solution was prepared by the cold method described 
by Schmolka (1972). Solutions of P407 in the range of 15 - 50% (w/v) were prepared by slowly 
dissolving the required amount of P407 over 2-3 min in 5 mL sterile distilled water at 2-4°C in 
20 mL glass vials and stirred using a magnetic stirrer. The vial was capped and left to stir for 
24 h at 2-4°C to ensure complete dissolution. The following tests were carried out at 24 h, 48 
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h, 72 h and at 7 days with the vials refrigerated at 2-4°C between each test. Three independent 
tests were carried out in triplicate to produce 9 sets of data. 
 
3.6.3.1 Injectability 
The ability to inject 1 mL aliquots of P407 at 24°C (room temperature) was tested using a sterile 
10 mL syringe (Becton, Dickinson and Co.) fitted with a 27-gauge Monoject™ needle 
(Sherwood Medical, St Louis, MO, USA).  
 
3.6.3.2 Tube inversion method 
Gelation of P407 samples was assessed at 37°C by inverting the vial to assess formulation flow. 
P407 at 25% (w/v) was found to be injectable at 24°C and gel at 37°C. 
 
3.6.3.3 In vitro gel stability studies 
In vitro stability testing was carried out to assess the rate of dissolution of P407 gel. One 
millilitre samples of 25% (w/v) P407 solution were incubated at 37°C in Eppendorf tubes to 
induce gelation. The initial weight of the gel was recorded as W1. Two hundred microlitres of 
PBS pre-warmed to 37°C was slowly added to the surface of the gel. The PBS was removed at 
pre-determined time intervals, the weight of the remaining gel recorded (W2) and the 
percentage gel weight loss calculated. This was repeated until the gel was completely degraded. 
P407 was found to be completely degraded after 6 days. The dissolution profile was obtained 
by plotting the cumulative weight of P407 gel formulations dissolved against time.  
 
3.6.3.4 In vitro release studies 
In vitro release of BM2 from P407 gel was assessed over 6 days, based on stability testing.  An 
aliquot of BM2 solution was thawed and diluted to produce a concentration of 400 µg/mL. P407 
(2.5 g) was slowly added over 2-3 min to 8 mL sterile distilled water at 2-4°C in 20 mL glass 
vials and stirred using a magnetic stirrer for 24 h to ensure complete dissolution. Eight hundred 
µL aliquots of P407 solution were placed into 1 mL Eppendorf tubes together with either 200 
µL of BM2 solution or 200 µL of sterile distilled water which served as a control to produce 1 
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mL 25% (w/v) gel formulations. The 1 mL gel formulations were left to stir for 24 h to ensure 
a homogenous solution. 
The 1 mL aliquots of the BM2-loaded P407 solution were incubated at 37°C to induce gelation. 
Two hundred µL of PBS pre-warmed to 37°C was slowly added to the surface of the gel. At 
pre-determined time intervals, the supernatant was removed, subjected to spectrophotometric 
analysis for assessment of BM2 content and replaced with an equal volume of PBS on the 
surface of the gel. The absorbance values attained at 280 nm were used to determine the 
concentration of BM2 (Ɛ280nm = 11,500 M
 -1cm-1) released, based on a standard curve (See 
Appendix A). 
Release profiles were expressed as a cumulative amount released as a function of time. 
 
3.7 Antimicrobial concentrations of BM2 
3.7.1 Minimum inhibitory concentration 
Based on a previous study (Yoganathan 2012), a BM2 stock solution of 3 mg/mL was made 
and serial 2-fold dilutions prepared in a 96 well microtitre plate (Greiner Bio-One GmbH) to 
give concentrations in the range of 20 – 1280 µg/mL. These samples were diluted 1:10 by taking 
20 µL aliquots and adding 180 µL of the previously prepared inoculum. Separate microtitre 
plates were set up for each microorganism (See Appendices B and C). The positive control 
wells contained 180 µL of inoculated broth and 20 µL of sterile water. The number of organisms 
per well was estimated to be 9 x 105 CFU for bacteria and 1.8 x 104 CFU for C. albicans. The 
wells at the periphery of each plate contained 180 µL of sterile broth and 20 µL of sterile water 
to serve as a negative control but also to minimise dehydration during incubation. 
The initial OD600nm was determined using a microtitre plate reader (Synergy 2, BioTek
®, 
Vermont, USA). Microtitre plates containing bacterial suspensions were incubated at 37°C for 
24 h under anaerobic conditions without shaking. The microtitre plate with fungal suspension 
was incubated at 30°C for 24 h aerobically with shaking.  
After incubation, microtitre plates were shaken over a vortex mixer. The negative control wells 
were checked for clarity to ensure the absence of growth, while the positive control wells were 
checked for turbidity to ensure growth had occurred. All test wells were assessed and the MIC 
read as the lowest concentration that inhibited the visible growth of the microorganism. This 
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was confirmed quantitatively by scanning the microtitre plates using a plate reader (Synergy 2, 
BioTek®) and recording the final cell density at OD600nm.  
This was repeated for P407 gel loaded with BM2 with concentrations in the range of 0 – 512 
µg/mL to determine the minimum inhibitory concentration required for each strain. Three 
independent tests were carried out for aqueous BM2 and P407 gel with BM2. 
 
3.7.2 Minimum bactericidal and fungicidal concentration 
Ten microlitre aliquots from the wells showing absence of growth were plated onto BHY agar 
for bacterial strains and YPD agar for C. albicans to determine the MBC and MFC, respectively. 
The agar plates were incubated accordingly for 24 h and assessed for growth. The lowest 
concentration in which no colonies were observed after incubation was determined to be the 
MBC or MFC. 
 
3.8 Susceptibility testing of microbial cells 
Based on determined MBC and MFC values and release studies, P407 gel was loaded with 
varied concentrations of BM2 and tested for its effects on planktonic cells and reduction in 
biofilm biomass. Three independent tests were carried out for each strain (n=15). 
 
3.8.1 Planktonic cells 
An aliquot of BM2 solution was thawed and serial 2-fold dilutions were carried out to produce 
concentrations in the range of 2 – 512 µg/mL of BM2. P407 was prepared as previously 
mentioned and was added to each prepared BM2 concentration ensuring a final concentration 
of 25% (w/v) P407.  
Six plates were set up for each strain, three for the P407 gel loaded with BM2 and three for 
aqueous BM2, incubated for either 24 h, 48 h, or 72 h. Plates were set up as shown in Table 




3.8.2 Monospecies biofilms 
3.8.2.1 Microtitre plate biofilm assay 
3.8.2.1.1 Biofilm formation 
Bacterial biofilms 
Bacterial cells were inoculated in 3 mL of TSB and grown to a stationary phase overnight. One 
mL of suspension was adjusted to OD600nm = 0.5 (~5 x 10
8 CFU/mL). The culture was diluted 
1:100 to 5 x 106 CFU/mL by adding 200 L to 19.8 mL of TSB. An inoculum of 180 L of the 
broth was added to each well of a 96 well microtitre plate (Greiner Bio-One GmbH) using a 
multi-channel pipette. The number of cells per well was estimated to be ~9 x 105 CFU. As a 
negative control, wells at the periphery of the microtitre plate were filled with 180 L of sterile 
TSB.  
The sterile plastic lids were replaced on the microtitre plates and the plates incubated at 37°C 
for 24 h in a modular atmosphere controlled system (Don Whitney Scientific Ltd, Stipley, West 
Yorkshire, UK). Planktonic microbes were removed from the microtitre plates after 12 h by 
removing 150 L of the growth medium and replacing it with 150 L sterile TSB. 
 
Fungal biofilms 
Fungal cells were inoculated in 3 mL of SD medium and grown to a stationary phase overnight. 
One mL of suspension was adjusted to OD600nm = 0.5 (~10
7 CFU/mL).The culture was diluted 
1:100 to 105 CFU/mL by adding 200 L to 19.8 mL of SD medium. An inoculum of 180 L of 
the broth was added to each well of a 96 well microtitre plate (Greiner Bio-One GmbH) using 
a multi-channel pipette. The number of cells per well is estimated to be 1.8 x 104 CFU. As a 
negative control, wells at the periphery of the microtitre plate were filled with 180 L of sterile 
SD medium.  
The sterile plastic lids were replaced on the microtitre plates and the plates incubated at 30°C 
aerobically with shaking. Planktonic microbes were removed from the microtitre plates after 12 
h by removing 150 L of the growth medium and replacing it with 150 L sterile SD medium. 
After incubation for 24 h, the growth medium was removed. Wells were washed at least twice 
with PBS. The removal of unattached microbes was considered complete once the PBS discard 
appeared clear.  
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3.8.2.1.2 Exposure of biofilm to antimicrobials 
An aliquot of BM2 solution was thawed and serial 2-fold dilutions were carried out to produce 
concentrations in the range of 2 – 512 µg/mL of BM2. P407 was prepared as previously 
mentioned and was added to each prepared BM2 concentration ensuring a final concentration 
of 25% (w/v) P407. Biofilms grown in microtitre plates were exposed to BM2-P407 
preparations, P407 gel, aqueous BM2 and saturated Ca(OH)₂ solution. Sterile PBS and sterile 
growth media (TSB or SD medium) served as controls. Washed wells with attached biofilms 
had 200 µL of test material added for 24, 48 or 72 h. Plates were set up as shown in Appendix 
F. Microtitre plates with bacterial biofilms were incubated anaerobically at 37°C and fungal 
biofilms incubated aerobically at 30°C with shaking. 
After each exposure period, the antimicrobials and controls were removed, wells washed 3 
times with sterile PBS and plates left to dry for 15 min. The effects of the substances on the 
biofilm were assessed using a crystal violet assay. 
 
3.8.2.2 Crystal violet assay 
A 0.1% crystal violet solution (Sigma-Aldrich®) was prepared and filtered aseptically using a 
sterile 25 mm diameter 0.22 µm syringe filter (Millex®, Merck Millipore) into a sterile glass 
universal bottle. 125 µL of crystal violet solution was added to each well and left to stain for 
10 min. Each plate was then inverted to remove the excess crystal violet solution. Wells were 
washed 3 times with PBS, the microtitre plate inverted on a paper towel, briskly tapped to 
remove excess liquid and left for 24 h to dry.  
200 µL of 95% ethanol was added to each well to solubilise the bound crystal violet. The lids 
of the microtitre plates were replaced and the ethanol left in the wells for 15 min at room 
temperature. The contents of the wells were mixed using a vortex mixer and the absorbance of 
each well was read at OD600nm (Synergy 2, BioTek
®). 
 
3.9 Statistical analysis 
Continuous variables are represented as means and standard deviation from the OD results, 
calculated using Microsoft Office Excel software. Statistical analysis was carried out using 
SPSS (IBM® SPSS® Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp). 
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Independent-samples t-tests were used to compare the means between two groups. One-way 
analysis of variance (ANOVA) tests with post-hoc Tukey’s honest significant difference (HSD) 
tests were carried out to compare the effects of concentration between more than two groups. P 





Chapter 4:   Results 
4.1 Poloxamer 407  
4.1.1 Formulation characterisation 
P407 containing the cationic AMP, BM2, was successfully prepared by the cold method as 
described by Schmolka (1972). A 25% (w/v) concentration of the polymer was chosen based 
on preliminary studies that assessed viscosity and injectability. At P407 concentrations below 
20% (w/v), the formulations existed as free-flowing liquids at ambient temperatures which were 
too flowable and not suitable to be syringed. At concentrations above 25% (w/v), the 
formulations were found to be too viscous at ambient temperatures and were not able to be 
syringed. All the P407 formulations formed gels within 2 minutes at 37°C. 
 
4.1.2 In vitro gel stability studies 
The in vitro dissolution profiles of the P407 gels with and without incorporated BM2 at 37°C 
are shown in Figure 4.1.2. For the control gel, 73.5%, 46.7%, and 33.6% of the gel remained 
intact after 24 h, 48 h, and 72 h respectively. For the BM2-loaded gel, 78.2%, 58.3%, and 32.4% 
of the gel remained intact after 24 h, 48 h, and 72 h respectively. Both formulations showed a 
similar dissolution profile and were completely dissolved by 132 h, indicating that BM2 caused 





Figure 4.1.2 In vitro gel stability of triblock copolymer hydrogel (P407) at 37°C in PBS over 
time. The values plotted are mean ± standard deviation where n=9. 
 
4.1.3 In vitro gel release studies 
The time dependence of in vitro release of BM2 from the P407 gel was determined by 
measuring the absorbance at 280nm associated with the tryptophan and phenylalanine of BM2. 
The supernatant obtained from P407 vials without BM2 served as a blank.  
Figure 4.1.3a illustrates the cumulative in vitro release of BM2 from P407 at 37°C. The amount 
released is shown as a percentage of the total BM2 initially loaded into the gel. The mean 
amount of BM2 released after 24 h, 48 h and 72 h was 17.4%, 26.1%, and 34.9% respectively. 
Figure 4.1.3b shows the linear correlation between the proportion of BM2 released and P407 































Figure 4.1.3a Time dependence of in vitro release of BM2 from P407 in PBS at 37°C. The 
percentages shown are calculated as a proportion of the initial BM2 loaded into P407 gel (400 
µg/mL). The values plotted are mean ± standard deviation where n=9. 
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4.2 Minimum inhibitory concentration of aqueous BM2 
The MIC values for BM2 against a panel of important endodontic pathogens are shown in Table 
4.2. These measurements were made as described in the materials and methods chapter by 
detecting light scattering using a microtitre plate reader to read optical density at 600nm (See 
Appendix H). Aqueous BM2 showed bacteriostatic activity against the different bacterial 
strains tested and fungistatic activity against Candida albicans. 
A BM2 concentration of 128 µg/mL completely inhibited the growth of all four strains. No 
growth was observed at this concentration after 24 h of incubation. Streptococcus mutans NG8 
was the most susceptible to BM2 with a MIC of 4 µg/mL. Enterococcus faecalis JH2-2 was the 
least susceptible to BM2 with a MIC of 64 µg/mL. The initial OD values appeared to be higher 
for concentrations of 64 µg/mL and 128 µg/mL for the three bacterial strains (See Appendices 
J-L). Although the OD values after 24 h were still high, they were significantly lower than the 
initial values. This, however, did not occur for C. albicans ATCC 10261 (See Appendix I).  
Table 4.2 MIC values of BM2. 
 
4.2.1 Candida albicans 
The growth of C. albicans ATCC 10261 (Figure 4.2.1) after 24 h incubation was found to be 
significantly higher at concentrations <32 µg/mL, as compared to concentrations ≥32 µg/mL (p 
< 0.001) (See Appendix I). There was a statistically significant difference between growth at 
16 µg/mL and 32 µg/mL (p = 0.001) but no significant difference between 32 µg/mL and 64 
µg/mL (p = 0.07). The overall growth at 64 µg/mL and 128 µg/mL, as shown in the graph, was 
negligible.  
Strain 
Minimum inhibitory concentration BM2 
(µg/mL) 
Candida albicans ATCC 10261 32 
Streptococcus gordonii DL1 16 
Streptococcus mutans NG8 4 
Enterococcus faecalis JH2-2 64 
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Figure 4.2.1 Growth of C. albicans ATCC 10261 after 24 hour exposure to varying 
concentrations of aqueous BM2. The OD values plotted are mean ± standard deviation where 
n=21. 
 
4.2.2 Streptococcus gordonii 
The growth of S. gordonii DL1 after exposure to aqueous BM2 is shown in Figure 4.2.2. 
Exposure to BM2 at concentrations <16 µg/mL resulted in significantly higher growth as 
compared to concentrations ≥16 µg/mL (p < 0.001) (See Appendix J). Negative OD values of 
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Figure 4.2.2 Growth of S. gordonii DL1 after 24 hour exposure to varying concentrations of 
aqueous BM2. The OD values plotted are mean ± standard deviation where n=21. 
  
4.2.3 Streptococcus mutans 
The mean OD values of S. mutans NG8 after exposure to aqueous BM2 for 24 h are shown in 
Figure 4.2.3. There was a significant difference between cell growth after exposure to 2 µg/mL 
and 4 µg/mL BM2 (p < 0.001) (See Appendix K). Similar to S. gordonii DL1, the OD values 
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Figure 4.2.3 Growth of S. mutans NG8 after 24 hour exposure to varying concentrations of 
aqueous BM2. The OD values plotted are mean ± standard deviation where n=21. 
 
4.2.4 Enterococcus faecalis 
The growth of E. faecalis JH2-2 after exposure to aqueous BM2 for 24 h is shown in Figure 
4.2.4. The mean growth at concentrations <64 µg/mL was significantly higher as compared to 
concentrations ≥64 µg/mL (p < 0.001) (See Appendix L). At 64 µg/mL, the mean initial OD 
values were not significantly different from OD values after 24 h (p = 0.084). Similar to S. 
gordonii DL1 and S. mutans NG8, OD values at 600nm were negative when exposed to 128 
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Figure 4.2.4 Growth of E. faecalis JH2-2 after 24 hour exposure to varying concentrations of 
aqueous BM2. The OD values plotted are mean ± standard deviation where n=21. 
 
4.3 Minimum fungicidal and bactericidal concentration 
The MFC and MBC values for BM2 are shown in Table 4.3. The most susceptible strain to 
BM2 was S. mutans NG8 with an MBC value of 8 µg/mL, while E. faecalis JH2-2 was found 
to be resistant to BM2 at the tested concentrations. BM2 demonstrated bacteriostatic and 
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4.4 Minimum inhibitory concentration of BM2-loaded P407 gel 
P407 loaded with BM2 exhibited bacteriostatic activity against the panel of microbial strains 
tested. The MIC values are shown in Table 4.4 and demonstrate that the combination of BM2 
with P407 retained antimicrobial activity. The MIC values were found to be 8-fold higher than 
those required for aqueous BM2 (See Appendix H). As was observed with aqueous BM2, S. 
mutans NG8 was the most susceptible of the strains tested to P407 with BM2 requiring a BM2 
concentration of 32 µg/mL. E. faecalis JH2-2 was the least susceptible requiring a BM2 
concentration >512 µg/mL. It is noted that the growth of E. faecalis JH2-2 was substantially 
(>90%) inhibited at 512 µg/mL BM2. 
  






concentration of BM2 
(µg/mL) 
Candida albicans ATCC 10261 128 
Streptococcus gordonii DL1 16 
Streptococcus mutans NG8 8 
Enterococcus faecalis JH2-2 > 128 
Strain 
Minimum inhibitory concentration of BM2-P407 
(µg/mL) 
Candida albicans ATCC 10261 256 
Streptococcus gordonii DL1 128 
Streptococcus mutans NG8 32 
Enterococcus faecalis JH2-2 >512 
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4.4.1 Candida albicans 
The growth of C albicans ATCC 10261 after exposure to BM2-loaded P407 gel was 
significantly higher at concentrations <256 µg/mL as compared to concentrations ≥256 µg/mL 
(p < 0.001) (See Appendix I). Growth after exposure to 256 µg/mL and 512 µg/mL BM2 was 
negligible (Figure 4.4.1) with no significant difference between the two concentrations (p = 
0.258). 
Figure 4.4.1 Growth of C. albicans ATCC 10261 after 24 hour exposure to varying 
concentrations of BM2 in P407 gel. The OD values plotted are mean ± standard deviation where 
n=15. 
 
4.4.2 Streptococcus gordonii 
The growth of S. gordonii DL1 was significantly higher when exposed to BM2 concentrations 
<128 µg/mL compared to ≥128 µg/mL (p < 0.001) (See Appendix J). Negative OD values were 
observed at concentrations of 256 µg/mL and 512 µg/mL BM2 in P407 (Figure 4.4.2) with a 
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Figure 4.4.2 Growth of S. gordonii DL1 after 24 hour exposure to varying concentrations of 
BM2 in P407 gel. The OD values plotted are mean ± standard deviation where n=15. 
 
4.4.3 Streptococcus mutans 
The growth of S. mutans NG8 was found to be significantly higher at BM2 concentrations in 
P407 <32 µg/mL compared to ≥32 µg/mL (p < 0.001) (See Appendix K). Similar to S. gordonii 


























Concentration of BM2 in P407 (µg/mL)
58 
 
Figure 4.4.3 Growth of S. mutans NG8 after 24 hour exposure to varying concentrations of 
BM2 in P407 gel. The OD values plotted are mean ± standard deviation where n=15. 
 
4.4.4 Enterococcus faecalis 
The growth of E. faecalis JH2-2 after exposure to BM2 in P407 gel is shown in Figure 4.4.4. 
Exposure to BM2, in gel, at all concentrations was found to result in statistically significant 
growth (p < 0.001) (See Appendix L). Growth at 512 µg/mL BM2 was significantly lower than 
concentrations <512 µg/mL but the OD values at 24 h were still statistically significant when 
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Figure 4.4.4 Growth of E. faecalis JH2-2 after 24 hour exposure to varying concentrations of 
BM2 in P407 gel medium. The OD values plotted are mean ± standard deviation where n=15. 
 
4.5 Susceptibility testing of planktonic cells 
The sets of OD600nm values obtained from susceptibility testing of planktonic cells of the test 
panel over 72 h are shown in Appendices D and E. The experimental agents (BM2, P407 gel 
alone, and BM2 incorporated into P407 gel) showed differing antimicrobial activities compared 
with the controls (sterile water and calcium hydroxide). The antimicrobial activity of BM2-
loaded P407 gel was compared to corresponding aqueous concentrations of the peptide, 
according to preliminary in vitro release studies using concentrations of BM2 expected to be 
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4.5.1 Candida albicans 
The growth of C. albicans ATCC 10261 incubated for 72 h with BM2 concentrations of 256 
µg/mL or 512 µg/mL in P407 was negligible (Figure 4.5.1a). Growth was significantly lower 
at these concentrations compared to P407 gel alone, calcium hydroxide and the sterile water 
control after 72 h (p < 0.001). No significant difference in growth was observed between BM2 
concentrations of 256 µg/mL or 512 µg/mL at any time period (p > 0.05).    
At concentrations of BM2 below 256 µg/mL, growth was highly statistically significant as 
compared to 256 µg/mL and 512 µg/mL (p < 0.001) (data not shown).  
After 24 h, growth of C. albicans was significantly lower with calcium hydroxide compared to 
P407 gel alone, BM2 in P407 at concentrations <256 µg/mL (data not shown), and sterile water 
(p < 0.001).  Growth, however, increased after 24 h to a level that was higher than all gel 
formulations up to 72 h. All gel formulations, including P407 without the incorporation of BM2 
as well as calcium hydroxide, showed significantly less growth compared to sterile water at all 
time periods (p < 0.001) (Figure 4.5.1a). 
Figure 4.5.1a Growth of C. albicans ATCC 10261 after exposure to P407 gel, P407 gel with 
256 µg/mL and 512 µg/mL, and controls (calcium hydroxide and sterile water) over 72 hours. 





































When compared to aqueous BM2, higher concentrations of BM2 were required when 
incorporated into a gel medium in order to elicit the same antimicrobial effects. After exposure 
for 24 h, an aqueous concentration of 32 µg/mL BM2 was required to inhibit growth of C. 
albicans. After 48 h and 72 h exposure, however, growth began to occur which was statistically 
significant from that after 24 h (p < 0.001) (Figure 4.5.1b). Figure 4.5.1b shows the growth of 
C. albicans when exposed to 256 µg/mL BM2 in P407 with the corresponding concentrations 
in solution, taking into consideration proportion of BM2 release from the gel (Figure 4.1.3a). 
A concentration of 128 µg/mL aqueous BM2 was required to block growth completely at a 
level comparable to 256 µg/mL BM2 incorporated into P407 (p = 0.5).  
Figure 4.5.1b Growth of C. albicans ATCC 10261 after exposure to 256 µg/mL BM2 
incorporated into P407 compared to corresponding aqueous concentrations over 72 hours. The 


































Figure 4.5.1c shows the growth of C. albicans when exposed to 512 µg/mL BM2 in P407 with 
the corresponding concentrations in solution. After 48 h exposure to 512 µg/mL BM2-loaded 
P407 gel, growth was significantly lower when compared to 64, 128, and 256 µg/mL aqueous 
BM2 (p < 0.001). After 72 h exposure, growth was significantly lower than 64 µg/mL and 128 
µg/mL BM2 (p < 0.001) but comparable to 256 µg/mL BM2 (p = 0.106).  
 
Figure 4.5.1c Growth of C. albicans ATCC 10261 after exposure to 512 µg/mL BM2 in P407 
compared to corresponding concentrations in solution over 72 hours. The OD values plotted 
are mean ± standard deviation where n=15. 
 
4.5.2 Streptococcus gordonii 
All gel formulations, including P407 alone, diminished cell growth significantly when S. 
gordonii DL1 was exposed for 72 h compared to 48 h (p < 0.001). The mean OD was found to 


































concentrations were associated with decreasing mean OD values with a significant reduction in 
OD with concentrations ≥64 µg/mL. 
The growth of S. gordonii DL1 after incubation for 72 h was negligible when exposed to BM2 
concentrations ≥128 µg/mL in P407 with negative overall OD values observed at 256 µg/mL 
and 512 µg/mL (Figure 4.4.2a). Significant differences were observed between 128 µg/mL, 256 
µg/mL, and 512 µg/mL BM2 (p < 0.001). Growth at these concentrations was significantly 
lower when compared to BM2 concentrations <128 µg/mL, P407 gel alone, calcium hydroxide 
and sterile water over the 72 h period (p < 0.001). 
Calcium hydroxide slightly inhibited the growth of S. gordonii DL1 when exposed for 24 h 
with OD values nearly comparable to that of the sterile water control. After 24 h, however, 
growth in the presence of calcium hydroxide was significantly higher as compared to all P407 
gel formulations and sterile water (Figure 4.5.2a) (p < 0.001). 
Figure 4.5.2a Growth of S. gordonii DL1 after exposure to P407 gel, P407 gel with 128 µg/mL, 
256 µg/mL and 512 µg/mL, and controls (calcium hydroxide and sterile water) over 72 hours. 



































Aqueous BM2 demonstrated antimicrobial activity at concentrations significantly lower than 
that of BM2-loaded P407, however, when taking into consideration proportion of release of 
BM2 from the gel, both mediums demonstrated comparable results. After exposure for 24 h, a 
concentration of 16 µg/mL BM2 in aqueous form elicited negligible growth. However, when 
exposed for a period of 72 h, an increase in growth was observed which was found to be 
significant from that after 24 h (p < 0.001) (Figure 4.5.2b). It was only at 64 µg/mL BM2 in 
solution that a bacteriostatic effect was observed over the 72 h time period. Aqueous 
concentrations >64 µg/mL resulted in no growth. 
Figure 4.5.2b shows the growth of S. gordonii when exposed to 128 µg/mL BM2 in P407. 
Preliminary release studies showed that approximately 26% and 35% of BM2 should be 
released from P407 after 48 h and 72 h respectively. When compared to the corresponding 
aqueous preparations of BM2 up to 32 µg/mL, BM2 in P407 gel medium at a concentration of 
128 µg/mL demonstrated significantly less growth after 48 h and 72 h (Figure 4.5.2b) (p < 
0.001). As expected, aqueous BM2 at 64 µg/mL was slightly more effective than 128 µg/mL 
BM2 in P407 gel (Figure 4.5.2b) and not as effective as 256 µg/mL BM2 in P407 gel (Figure 
4.5.2c). 
Figure 4.5.2b Growth of S. gordonii DL1 after exposure to 128 µg/mL BM2 in P407 compared 
to corresponding concentrations in solution over 72 hours. The OD values plotted are mean ± 



































Figure 4.5.2c shows the growth of S. gordonii DL1 after exposure to 256 µg/mL BM2 in P407 
with the equivalent aqueous concentrations. After 48 h, S. gordonii exhibited significantly less 
growth with 256 µg/mL BM2 in a gel medium compared to 64 µg/mL BM2 in aqueous form 
(p < 0.001). 
Figure 4.5.2c Growth of S. gordonii DL1 after exposure to 256 µg/mL BM2 in P407 compared 
to corresponding concentrations in solution over 72 hours. The OD values plotted are mean ± 
standard deviation where n=15. 
. 
4.5.3 Streptococcus mutans 
P407 alone appeared to have no antimicrobial effect on S. mutans NG8 with OD values 
comparable to sterile water (p = 0.670). The incorporation of BM2, however, into P407 

































The growth of S. mutans NG8 after incubation for 72 h was negligible when exposed to BM2 
in P407 gel at concentrations ≥32 µg/mL. When compared to P407 gel, P407 gel with BM2 
concentrations <32 µg/mL, calcium hydroxide and sterile water, there was significantly less 
growth with BM2 concentrations ≥32 µg/mL (p < 0.001). No significant differences were 
observed between concentrations of 32-256 µg/mL (p > 0.05) at any time period but a 
significant reduction in OD was found for 512 µg/mL (p < 0.001) (data not shown). 
Growth was significantly higher with calcium hydroxide compared to all experimental groups 
as well as P407 gel alone and sterile water at all time periods (p < 0.001) (Figure 4.5.3a). 
Figure 4.5.3a Growth of S. mutans NG8 after exposure to P407 gel, P407 gel with 16 µg/mL, 
32 µg/mL and 64 µg/mL, and controls (calcium hydroxide and sterile water) over 72 hours. The 
OD values plotted are mean ± standard deviation where n=15. 
When compared to aqueous BM2, higher concentrations of BM2 were required when using a 
gel medium to elicit the same antimicrobial effects. After exposure for 24 h, a concentration of 



































from 2 µg/mL (p < 0.001). After 48 h and 72 h exposure, however, growth began to occur which 
was statistically significant from that after 24 h (p < 0.001). Concentrations ≥8 µg/mL resulted 
in negligible growth at all time periods.  
The growth of S. mutans when exposed to BM2 at a concentration of 32 µg/mL in P407 gel is 
shown in Figure 4.5.3b, together with the aqueous counterparts. After 48 h, approximately 8 
µg/mL of BM2 should be released from P407 loaded with 32 µg/mL BM2, according to in vitro 
release testing. The growth of S. mutans when exposed to P407 loaded with 32 µg/mL BM2 for 
48 h, however, was found to be significantly lower than growth after exposure to 8 µg/mL 
aqueous BM2. After 72 h, there was no significant difference between BM2-loaded P407 at a 
concentration of 32 µg/mL and 16 µg/mL BM2 in solution (p = 0.418). 
Figure 4.5.3b Growth of S. mutans NG8 after exposure to 32 µg/mL BM2 in P407 compared 
to corresponding aqueous concentrations over 72 hours. The OD values plotted are mean ± 
































4.5.4 Enterococcus faecalis 
The growth of E. faecalis JH2-2 was negligible only when exposed to P407 loaded with 512 
µg/mL BM2. Slight growth occurred after 24 h, however, after 48 h and 72 h no growth was 
observed (Figure 4.5.4a). Considerable growth occurred in the presence of P407 gel alone, 
calcium hydroxide, and sterile water within 24 h (p < 0.001).  
All gel formulations including P407 alone demonstrated some antimicrobial activity, 
represented by mean OD values which were significantly lower as compared to calcium 
hydroxide and sterile water (p < 0.001). All formulations resulted in OD values which decreased 
with time. 
When exposed to calcium hydroxide, the growth of E. faecalis was found to be significantly 
lower compared to sterile water (p < 0.001) but still significantly higher than all gel 
formulations (p < 0.001).   
Figure 4.5.4a Growth of E. faecalis JH2-2 after exposure to P407 gel, P407 gel with 256 µg/mL 
and 512 µg/mL, and controls (calcium hydroxide and sterile water) over 72 hours. The OD 

































The growth of E. faecalis after exposure to 512 µg/mL BM2 in P407 gel was compared to the 
aqueous BM2 concentrations expected to be released from the gel. After 48 h, growth was 
completely inhibited when exposed to 512 µg/mL BM2 in P407, which was significantly lower 
than the corresponding aqueous BM2 concentration of 128 µg/mL (Figure 4.5.4b).  
 
Figure 4.5.4b Growth of E. faecalis JH2-2 after exposure to 512 µg/mL BM2 in P407 
compared to corresponding aqueous concentrations over 72 hours. The OD values plotted are 





































4.6 Susceptibility testing of monospecies biofilms 
The crystal violet assay was used to assess the susceptibility of the 4 strains used in this study 
to BM2 in P407 gel by comparison with saturated calcium hydroxide. Absorbance was 
measured at 600 nm to determine the level of eluted crystal violet and the values used to 
quantify the biomass of attached biofilm. The mean absorbance values at each time period are 
shown in Tables 4.6.1 – 4.6.4. Representative microtitre plate wells from each experimental 
and control group after exposure to BM2 of 24 h biofilms for up to 72 h prior to dissolution of 
the crystal violet dye are shown in the tables.  
 
4.6.1 Candida albicans 
The mean absorbance of C. albicans ATCC 10261 biofilms grown for 24 h was 2.665 ± 0.196. 
The mean absorbance values after exposure of these biofilms to the experimental agents and 
controls over 72 h are shown in Tables 4.6.1a and 4.6.1b. Untreated biofilms gave a mean 
absorbance of 9.776 ± 0.157 after 72 h. Control biofilms exposed to PBS for 72 h had a mean 
absorbance of 3.304 ± 0.099. Exposure to BM2 concentrations in P407 ≥256 µg/mL inhibited 
biofilm growth and attachment significantly at all exposure times (p < 0.001) (Figure 4.6.1). A 
BM2 concentration of 128 µg/mL gave significant growth after exposure for 24 h (p < 0.001). 
After 24 h, the biomass remained relatively constant with no significant change when compared 
to concentrations <128 µg/mL (p > 0.05). Saturated calcium hydroxide performed similarly to 











Table 4.6.1a C. albicans biofilm biomass following exposure to varying concentrations of BM2 
in P407 over 72 hours and representative microtitre plate wells with crystal violet stain after 
exposure for 72 hours. The OD values are mean ± standard deviation where n=15. 
Concentration 
of BM2 in P407 
(µg/mL) 
Time (h) CV stain 
after 72 h  0 24 48 72 
0 2.640 ± 0.139 4.098 ± 0.182 5.100 ± 0.107 5.970 ± 0.121 
 
2 2.678 ± 0.311 4.002 ± 0.145 5.080 ± 0.131 5.890 ± 0.105 
 
4 2.762 ± 0.179 4.028 ± 0.145 5.074 ± 0.109 5.728 ± 0.192 
 
8 2.736 ± 0.250 4.012 ± 0.104 4.920 ± 0.148 5.502 ± 0.126 
 
16 2.686 ± 0.122 4.090 ± 0.167 4.950 ± 0.155 5.560 ± 0.157 
 
32 2.652 ± 0.191 4.026 ± 0.117 4.840 ± 0.119 5.528 ± 0.113 
 
64 2.708 ± 0154 3.964 ± 0.077 4.756 ± 0.137 5.636 ± 0.128 
 
128 2.742 ± 0.144 3.554 ± 0.121 3.676 ± 0.093 3.806 ± 0.102 
 
256 2.566 ± 0.119 1.314 ± 0.146 0.870 ± 0.052 0.634 ± 0.017 
 




Table 4.6.1b C. albicans biofilm biomass following exposure to controls over 72 hours and 
representative microtitre plate wells with crystal violet stain after exposure for 72 hours. The 
OD values are mean ± standard deviation where n=15. 
Concentration 
of BM2 in P407 
(µg/mL) 
Time (h) CV stain 
after 72 h 0 24 48 72 
Ca(OH)2 2.656 ± 0.151 2.956 ± 0.102 4.152 ± 0.150 5.260 ± 0.154 
 




2.584 ± 0.182 6.492 ± 0.094 7.774 ± 0.122 9.776 ± 0.157 
 
Figure 4.6.1 C. albicans biofilm biomass following exposure to experimental agents and 
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4.6.2 Streptococcus gordonii 
The mean OD of S. gordonii DL1 biofilms was 1.898 ± 0.147 after 24 h. The mean OD values 
after exposure to all experimental agents and controls over 72 h is shown in Tables 4.6.2a and 
4.6.2b. Control biofilms exposed to PBS for 72 h had a mean OD of 4.470 ± 0.319, however, 
significant growth was observed over this period (p < 0.001). Biofilm biomass disruption was 
observed at BM2 concentrations ≥ 128 µg/mL over 72 h while growth was observed for 
concentrations < 128 µg/mL. BM2 at a concentration of 64 µg/mL resulted in initial growth, 
however, demonstrated disruption of the biofilm after 24 h.  
Exposure to saturated calcium hydroxide for 72 h resulted in growth which was significantly 
higher than growth after exposure to all BM2-loaded gels (p < 0.001).  Figure 4.6.2 shows the 
effect of BM2 concentrations of 64 µg/mL and higher on the biomass after 72 h compared to 
PBS and saturated calcium hydroxide. 
 
Table 4.6.2a S. gordonii biofilm biomass following exposure to varying concentrations of BM2 
in P407 over 72 hours and representative microtitre plate wells with crystal violet stain after 
exposure for 72 hours. The OD values are mean ± standard deviation where n=15. 
Concentration 
of BM2 in P407 
(µg/mL) 
Time (h) CV stain 
after 72 h 0 24 48 72 
0 1.926 ± 0.141 3.476 ± 0.151 4.874 ± 0.225 5.080 ± 0.120 
 
2 1.924 ± 0.133 3.534 ± 0.138 4.494 ± 0.165 4.914 ± 0.193 
 
4 1.884 ± 0.209 3.546 ± 0.147 4.112 ± 0.213 4.704 ± 0.116 
 
8 1.962 ± 0.206 3.454 ± 0.164 3.980 ± 0.139 4.584 ± 0.190 
 




32 1.872 ± 0.101 3.234 ± 0.155 3.794 ± 0.124 4.264 ± 0.131 
 
64 1.956 ± 0.173 3.336 ± 0.089 3.060 ± 0.059 2.356 ± 0.088 
 
128 1.956 ± 0.123 1.842 ± 0.108 1.780 ± 0.143 1.684 ± 0.118 
 
256 1.914 ± 0.094 1.810 ± 0.091 1.680 ± 0.099 1.504 ± 0.106 
 




Table 4.6.2b S. gordonii biofilm biomass following exposure to controls over 72 hours and 
representative microtitre plate wells with crystal violet stain after exposure for 72 hours. The 
OD values are mean ± standard deviation where n=15. 
Concentration 
of BM2 in P407 
(µg/mL) 
Time (h) CV stain 
after 72 h 0 24 48 72 
Ca(OH)2 1.818 ± 0.079 3.336 ± 0.105 4.756 ± 0.173 5.654 ± 0.136 
 










Figure 4.6.2 S. gordonii biofilm biomass following exposure to experimental agents and 
controls for 72 hours. The OD values plotted are mean ± standard deviation where n=15. 
 
4.6.3 Streptococcus mutans 
The mean OD of S. mutans NG8 biofilms after 24 h was 1.862 ± 0.117. The mean OD values 
after exposure to all experimental agents and controls over 72 h are shown in Tables 4.6.3a and 
4.6.3b. After 72 h, the mean OD of S. mutans biofilms exposed to PBS was 4.052 ± 0.151. 
Significant biofilm detachment was observed when exposed to BM2-loaded P407 at 
concentrations ≥ 32 µg/mL for 72 h.  
Saturated calcium hydroxide also demonstrated biofilm disruption which was statistically 
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Table 4.6.3a S. mutans biofilm biomass following exposure to varying concentrations of BM2 
in P407 over 72 hours and representative microtitre plate wells with crystal violet stain after 
exposure for 72 hours. The OD values are mean ± standard deviation where n=15. 
Concentration 
of BM2 in P407 
(µg/mL) 
Time (h) CV stain 
after 72 h 0 24 48 72 
0 1.890 ± 0.114 4.190 ± 0.306 5.670 ± 0.243 6.402 ± 0.278 
 
2 1.850 ± 0.094 3.632 ± 0.190 4.938 ± 0.229 6.102 ± 0.089 
 
4 1.834 ± 0.119 3.494 ± 0.090 4.646 ± 0.241 5.938 ± 0.251 
 
8 1.848 ± 0.165 3.490 ± 0.210 4.724 ± 0.310 5.978 ± 0.269 
 
16 1.814 ± 0.074 3.210 ± 0.270 3.560 ± 0.131 3.710 ± 0.112 
 
32 1.850 ± 0.107 1.816 ± 0.090 1.758 ± 0.095 1.672 ± 0.051 
 
64 1.878 ± 0.103 1.834 ± 0.080 1.738 ± 0.053 1.676 ± 0.054 
 
128 1.870 ± 0.122 1.790 ± 0.068 1.690 ± 0.040 1.520 ± 0.061 
 
256 1.888 ± 0.083 1.784 ± 0.076 1.684 ± 0.041 1.468 ± 0.054 
 




Table 4.6.3b S. mutans biofilm biomass following exposure to controls over 72 hours and 
representative microtitre plate wells with crystal violet stain after exposure for 72 hours. The 
OD values are mean ± standard deviation where n=15. 
Concentration 
of BM2 in P407 
(µg/mL) 
Time (h) CV stain 
after 72 h 0 24 48 72 
Ca(OH)2 1.908 ± 0.142 4.534 ± 0.219 3.178 ± 0.084 2.222 ± 0.148 
 




1.828 ± 0.089 6.216 ± 0.135 7.730 ± 0.207 8.856 ± 0.209 
 
Figure 4.6.3 S. mutans biofilm biomass following exposure to experimental agents and controls 
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4.6.4 Enterococcus faecalis 
The mean OD of E. faecalis JH2-2 biofilms was 0.422 ± 0.020 after 24 h, which was found to 
be significantly lower than the other bacterial biofilms (p < 0.001). The mean OD values after 
exposure to all experimental agents and controls over 72 h are shown in Tables 4.6.4a and 
4.6.4b. The mean OD of control biofilms exposed to PBS for 72 h was 0.475 ± 0.008. A BM2 
concentration of 512 µg/mL in gel medium was required in order to disrupt the biofilm with a 
mean OD of 0.253 ± 0.015 after exposure for 72 h (Figure 4.6.4). BM2 concentrations < 512 
µg/mL resulted in growth at all time periods with OD values significantly higher than PBS (p 
< 0.001).  
Saturated calcium hydroxide did not appear to cause any biofilm detachment, with an increase 
in the mean OD over 72 h which was significantly higher than all gel formulations (p < 0.001). 
 
Table 4.6.4a E. faecalis biofilm biomass following exposure to varying concentrations of BM2 
in P407 over 72 hours and representative microtitre plate wells with crystal violet stain after 
exposure for 72 hours. The OD values are mean ± standard deviation where n=15. 
Concentration 
of BM2 in P407 
(µg/mL) 
Time (h) CV stain 
after 72 h 0 24 48 72 
0 0.411 ± 0.017 0.608 ± 0.019 0.716 ± 0.015 0.832 ± 0.010 
 
2 0.416 ± 0.020 0.594 ± 0.012 0.694 ± 0.016 0.816 ± 0.014 
 
4 0.428 ± 0.020 0.593 ± 0.017 0.699 ± 0.009 0.815 ± 0.008 
 
8 0.434 ± 0.010 0.588 ± 0.013 0.695 ± 0.008 0.799 ± 0.018 
 




32 0.424 ± 0.023 0.570 ± 0.016 0.671 ± 0.015 0.787 ± 0.021 
 
64 0.427 ± 0.022 0.577 ± 0.012 0.666 ± 0.018 0.776 ± 0.020 
 
128 0.433 ± 0.021 0.571 ± 0.007 0.646 ± 0.017 0.742 ± 0.019 
 
256 0.421 ± 0.025 0.539 ± 0.019 0.550 ± 0.020 0.562 ± 0.013 
 




Table 4.6.4b E. faecalis biofilm biomass following exposure to controls over 72 hours and 
representative microtitre plate wells with crystal violet stain after exposure for 72 hours. The 
OD values plotted are ± standard deviation where n=15. 
Concentration 
of BM2 in P407 
(µg/mL) 
Time (h) CV stain 





































Figure 4.6.4 E. faecalis biofilm biomass following exposure to experimental agents and 
controls for 72 hours. The OD values plotted are mean ± standard deviation where n=15. 
 
4.6.5 Summary  
Determination of biofilm biomass of 24 h biofilms treated for up to 72 h with BM2 incorporated 
into P407 gels gave dose-dependent growth impairment for all 4 strains in the test panel and, in 
most cases, significantly disrupted biofilm detachment. A concentration of 512 µg/mL BM2 
was able to disrupt all biofilms.  
As found with planktonic cells, the biofilm formed by S. mutans NG8 appeared to be the most 
susceptible to BM2 while that of E. faecalis JH2-2 appeared to be the most resistant. Saturated 
calcium hydroxide was most effective in inhibiting growth of the S. mutans 24 h biofilm, slowed 
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Chapter 5:   Discussion 
The aim of the present study was to produce a sustained release gel suitable for the intracanal 
administration of the cationic AMP, BM2, and to assess the in vitro effect of this gel on common 
endodontic pathogens. Comparison was also made between the antimicrobial efficacy of BM2 
in a gel formulation and in aqueous solution.  
 
5.1 Poloxamer gel formulation 
The basic goal of therapy is to achieve a steady-state tissue level of drug that is therapeutically 
effective and nontoxic for an extended period of time. Attempts have been made to sustain local 
drug levels and increase their therapeutic efficacy. The use of Poloxamer 407 polymer gels for 
the controlled delivery of drugs is well documented. These gels have been utilised for the 
delivery of antibiotics (Esposito et al. 1996, Veyries et al. 1999, Zhang et al. 2002), anti-
inflammatory drugs (Miyazaki et al. 1995, Newa et al. 2008), anticancer drugs (Miyazaki et al. 
1984, Amiji et al. 2002, Saxena & Hussain 2012), anaesthetics such as lidocaine (Chen-Chow 
& Frank 1981, Ricci et al. 2005), and biologically active proteins/peptides such as interleukin-
2 (Johnston et al. 1992), melanotan-I (Bhardwaj & Blanchard 1996), and urease (Fults & 
Johnston 1990, Pec et al. 1992). Due to the pharmacological properties of P407, it was chosen 
as a polymer for delivery of BM2. 
For the present study, the concentration of P407 had to meet the criteria of being free-flowing 
at room temperature but a viscous gel at 37°C. This was chosen on the basis of ease of 
administration by syringe at room temperature and transition to a gel when placed into the root 
canal system at body temperature. Various concentrations of P407 ranging from 15-50% (w/v) 
were evaluated. At concentrations below 20% (w/v), P407 formulations were solutions at 
ambient temperatures. A concentration of 20% (w/v) was found to have suitable viscosity but 
previous studies have shown increased dissolution rates with low concentrations and increased 
stability with higher concentrations (Chi & Jun 1991, El Gendy et al. 2002). As such, at 25% 
(w/v) P407 formulation was found to be easy to manipulate and inject, facilitating convenient 
administration of BM2 into the root canal system.    
In vitro stability and release profiles provide important information about the efficiency of a 
drug delivery system. The model of choice should resemble the in vivo behaviour as closely as 
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possible so the results can be extrapolated. In vitro stability and release studies were performed 
using a membrane dissolution model. The advantage of this model is that gel formulation is in 
direct contact with the release medium, and consequently, formulation factors affecting drug 
release can be readily discerned (Bhardwaj & Blanchard 1996). 
Poloxamers are swelling-controlled systems that function by a process of continuous swelling 
of the polymer carrier that is associated with simultaneous or subsequent dissolution (Zhang et 
al. 2002). Drug release is controlled by the surface hydration rate. The P407 gels are viewed as 
consisting of large populations of micelles and aqueous channels in which the incorporated 
solute may be released by its passage through these aqueous channels and from gel dissolution 
(Gilbert et al. 1986, Bhardwaj & Blanchard 1996). The size of the aqueous channels, the 
arrangement of the drug between the micelles and the aqueous phase, and the microviscosity of 
the extramicellar fluid can affect release of the drug (Chen-Chow & Frank 1981, Rassing & 
Attwood 1983). At low temperatures, P407 forms micellar subunits in solution. As the 
temperature increases, micellar desolvation and swelling gives rise to large micelles and the 
creation of a cross-linked network (Chen-Chow & Frank. 1981, Alexandridis & Hatton 1995). 
The result of this phenomenon is an increase in viscosity on heating (Veyries et al. 1999).  
Gel properties can change with the addition of a drug. These include alterations to the sol-gel 
transition temperature (Vadnere et al. 1984, Gilbert et al. 1987) and consequently, interference 
with the gelation process (Ricci et al. 2002). In this study, sustained release Poloxamer gel 
formulations containing BM2 were developed and evaluated in vitro. Incorporation of BM2 
into the P407 gels did not appear to affect the overall gel stability with no alteration to the rate 
of dissolution, supporting the first hypothesis of this study. The second hypothesis was that 
BM2 would be released over a period of time from the P407 gel. The BM2 release profile, as 
shown in Figure 4.1.3a correlated well with the dissolution rate of the P407 gels (Figure 4.1.3b), 
however, it was evident from the in vitro release studies that the entire weight of peptide 
incorporated into the P407 gel was not released, despite complete dissolution of the gel. This 
may be attributed to possible alteration to the state of the peptide or the inability to detect the 
peptide through spectrophotometric analysis at 280nm. It is postulated that some of the BM2 
may have been deactivated or degraded. When compared to the availability of BM2 in solution, 
the amount of BM2 released from P407 gel formulations was 8-fold with complete gel 
dissolution occurring over 4-5 days. Although the literature on drug release indicates that 
release occurs through passage through aqueous channels, there are currently no studies on how 
BM2 is incorporated into the gel matrix and the exact mechanism of release. Based on previous 
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reports with other compounds, we assume that BM2 is released via gel dissolution and 
subsequent release into the aqueous channels (Bhardwaj & Blanchard 1996, Moore et al. 2000). 
BM2 retained its antimicrobial activity as shown in the susceptibility testing on planktonic cells 
(Figures 4.5.1-4.5.4) and using the crystal violet assay model (Tables 4.6.1-4.6.4 and Figures 
4.6.1-4.6.4). This is in accordance with other studies showing that drugs released from P407 
retain their therapeutic activity (Mengi & Deshpande 1992, Esposito et al. 1996). 
Poloxamers have been used as surfactants for several years which has led to the discovery of 
their biological activity. They can interact with cell membranes and modify membrane 
permeability for certain compounds such as drugs (Takáts et al. 2001). The results of the current 
study found that all gel formulations, including P407 alone, resulted in microbial growth that 
was significantly lower than sterile water. The potential of P407 for inhibiting bacterial 
attachment and growth and increasing their susceptibility to antibiotics has been demonstrated 
(Veyries et al. 2000). BM2 exhibited antimicrobial activity in both aqueous and gel form, 
however, the effects were observed at lower concentrations and occurred faster in aqueous form 
compared to gel form due to the drug availability. The gel medium demonstrated more sustained 
effects.  
Poloxamer 407 gels are novel drug delivery systems which this study has highlighted to be a 
promising carrier for BM2. This study has shown the potential of BM2 incorporated into P407 
gels to be antimicrobial against the endodontic strains tested in vitro. If this combination can 
be shown to be effective against other common members of the endodontic microflora, this gel 
may be considered as a suitable intracanal medicament for disinfection of the root canal system 
during root canal treatment. The tissue-dissolving capacity is, however, not yet known and 
before BM2 incorporated into a P407 gel can be considered as a potential intracanal 
medicament, further studies need to be carried out to assess this.  
 
5.2 Planktonic cell cultures 
Streptococcus species have been implicated in the initiation and progression of endodontic 
infections (Love et al. 2000, Love & Jenkinson 2002). S. gordonii and S. mutans are well known 
as predominant bacterial species present in the oral cavity that have been implicated as early 
colonisers in dental plaque (Nyvad & Kilian 1987, Jenkinson & Lamont 1997). There is 
evidence of invasion of dentinal tubules showing that they may be responsible for the initiation 
of pulpal infection (Love et al. 1997, Love & Jenkinson 2002). In addition to this, they provide 
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additional binding sites for the subsequent attachment of microorganisms (Svensäter & 
Bergenholtz 2004). As a result, both S. mutans and S. gordonii were selected for this research. 
E. faecalis has been found to be a commensal microorganism of the root-filled tooth which can 
survive initial treatment but may not necessarily be causative of treatment failure (Fabricius et 
al. 1982a, Kaufman et al. 2005). It has the potential to become pathogenic and has been 
cultivated from obturated root canals of teeth with persistent periapical pathology (Molander et 
al. 1998, Sundqvist et al. 1998, Hancock III et al. 2001). E. faecalis has been found to be 
difficult to eradicate using current intracanal medicaments (Haapasalo & Ørstavik 1987, Saleh 
et al. 2004). C. albicans has also been recognised as a commensal microorganism that can 
become pathogenic under certain conditions (Sen et al. 1995). Similar to E. faecalis, it has been 
reported to show resistance to calcium hydroxide (Waltimo et al. 1999). Due to the difficulty 
in eradicating these organisms, they were chosen for this study. 
The results of the minimum inhibitory and bactericidal/fungicidal tests as well as the 
susceptibility tests on planktonic cells over an extended period validated the third hypothesis 
of this study which was that the species tested will be susceptible to BM2-loaded P407 gels at 
varying concentrations. All strains were found to be susceptible to BM2 in aqueous and gel 
medium with S. mutans being the most susceptible and E. faecalis being the most resistant.  
BM2 was found to exert both fungistatic and fungicidal effects on C. albicans when 
administered in P407 gel. Inhibitory effects were observed at a concentration of 256 µg/mL 
with apparent fungicidal effects at 512 µg/mL. Growth occurred initially at 128 µg/mL BM2 in 
P407 gel but BM2 appeared to block growth after 24 hours. This effect is most likely due to the 
initial release of a concentration of peptide that was inadequate at inhibiting growth of C. 
albicans.  
The bacteriostatic and bactericidal properties of BM2-loaded P407 gels were also highlighted 
in this study. BM2 in P407 exhibited bacteriostatic effects on S. gordonii at a concentration of 
128 µg/mL and exhibited bactericidal effects at concentrations greater than 256 µg/mL. For S. 
mutans, 32 µg/mL BM2 in P407 was effective at inhibiting growth while concentrations greater 
than 32 µg/mL were effective at killing S. mutans planktonic cells. BM2 was ineffective at 
inhibiting or killing E. faecalis in planktonic culture when exposed for 24 hours, however, 
bactericidal effects were observed when exposed for longer periods to 512 µg/mL.  
Based on these results, the antimicrobial effects of BM2 were dose-dependent with a 
concentration of 512 µg/mL incorporated into P407 being the most effective at inhibiting and 
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perhaps even killing all 4 strains. Cationic peptides preferentially bind to acidic phospholipids, 
acidic polysaccharides, and lipopolysaccharides on the surface of lipid bilayer of microbes. 
Such peptides appear to exert antimicrobial effects by forming structures which can affect the 
integrity of the lipid bilayer and disrupt the membrane (Dathe & Wieprecht 1999, Matsuzaki 
1999, Shai 1999). The antimicrobial properties of BM2 may be related to its configuration, 
being composed of D-amino acids. D-peptides have been shown to be resistant to enzymatic 
degradation and have been reported to be more stable than their L-isomeric forms (Wade et al. 
1990). Moreover, peptides containing D-amino acids can be more biologically potent. It has 
been proposed that D-peptides first associate with the membrane by electrostatic forces and 
then the helical molecules span the lipid bilayer (Wade et al. 1990). There are no studies on the 
mechanism in which BM2 exerts in antibacterial properties and hence, it can only be postulated 
that ion-channel pores are formed. Additionally, BM2 is comprised of a triarginine motif with 
amidation of the C-terminus. The cationic charge of arginine provides an effective means of 
attracting BM2 to the target membranes and the opportunities for ionic bonding should facilitate 
its interaction with the negatively charged surfaces of the lipid bilayer (Chan et al. 2006).  
In line with the third hypothesis, these results support the use of BM2 in a thermoresponsive 
P407 gel medium which allowed the peptide to retain its antimicrobial properties.  
 
5.3 Antimicrobial activity against monospecies biofilms 
The development of biofilms presents significant treatment problems because pathogens in the 
biofilm can be highly resistant to treatment, especially with antibiotics. Once the microbial 
communities form, they are difficult to eradicate with conventional therapies. Bacterial biofilms 
have become important targets for drug discovery (Kwasny & Opperman 2010). 
The current in vitro study showed that BM2-loaded P407 gels had fungicidal and bactericidal 
effects against biofilms of the selected strains, corroborating the fourth hypothesis.  
Further growth of C. albicans was inhibited when exposed to BM2 concentrations of 128 
µg/mL but concentrations greater than 128 µg/mL resulted in a significant reduction of the 
biomass with the crystal violet assay. When exposed to 256 µg/mL and 512 µg/mL BM2, there 
was a 75% and 82% reduction in the biomass, respectively. These results demonstrate the 
fungicidal potential of BM2, which most likely occurs as a result of inhibition of the essential 
enzyme, Pma1p, an ATPase required for fungal energy transduction (Monk et al. 2005). 
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BM2 was inhibitory against S. gordonii and S. mutans biofilms at concentrations as low as 16 
µg/mL with absorbance values comparable to PBS. BM2 was bactericidal against S. gordonii 
biofilms or caused biofilm detachment at concentrations of 128 µg/mL and higher with a 33% 
reduction in the bacterial biomass when exposed to BM2 at a concentration of 512 µg/mL. For 
S. mutans, BM2 was bactericidal or caused biofilm detachment at concentrations of 32 µg/mL 
and higher with a maximum reduction in the bacterial biomass of 29% after exposure to BM2 
at a concentration of 512 µg/mL. E. faecalis biofilms were the most difficult to target requiring 
BM2 concentrations of 512 µg/mL to elicit bactericidal effects. The results indicated a 38% 
reduction in the biomass using the crystal violet assay. 
BM2-loaded P407 gels gave greater reduction in fungal biofilms compared to bacterial biofilms 
with BM2-loaded P407 gels. As previously noted, BM2 targets fungal cells via the membrane 
protein, Pma1p, which is only present in fungi (Serrano et al. 1986). Based on the results, it is 
likely that BM2 has a different mechanism of action on bacterial cells, a point which remains 
to be investigated.  
Calcium hydroxide significantly reduced the biomass of S. mutans biofilms, but was ineffective 
for C. albicans, S. gordonii and E. faecalis biofilms. For all biofilms, including S. mutans, 
calcium hydroxide was a less effective antimicrobial than BM2-loaded P407 gels which gave 
significantly greater reduction in biomass at 512 µg/mL incorporated peptide. Based on these 
results, BM2 incorporated into a P407 medium is more effective than calcium hydroxide against 
monospecies biofilms, thereby refuting the final hypothesis. 
 
5.4 Experimental design and limitations 
For this study, a membraneless dissolution model was used to assess the stability of P407 and 
release of BM2. This model posed potential sources of error due to difficulties in removing the 
receptor medium for spectrophotometric analysis. Difficulties were encountered in accurately 
sampling the PBS solution. Its efficient removal required considerable care in avoiding 
disruption of the P407 surface. Errors were minimised by using replicate of experiments. The 
other limitations of using a membraneless dissolution model is that this procedure is greatly 
influenced by stirring speed and experimental set-up, including temperature of the receptor 
medium. Preheating of the receptor medium does not mimic in vivo conditions (Dumortier et 
al. 2006). Finally, release at the interface has been postulated to occur via diffusion while the 
remainder of the drug is released during gel dissolution (Anderson et al. 2001).  
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Peptides have the tendency to precipitate and bind avidly to the surface of target cells or plastic 
materials such as polystyrene, complicating evaluation of the in vitro antimicrobial activities 
(Hancock 1997, Wu & Hancock 1999, Giacometti et al. 2000). Giacometti et al. 2000 showed 
that cationic AMPs possessed higher antimicrobial activities when polypropylene materials 
were used. Another study by the same group recommended shaking microtitre plates during 
incubation to reduce precipitation (Giacometti et al. 1999). In the present study, BM2 appeared 
to precipitate at higher concentrations when combined with the bacterial inoculums. This was 
detected by visual inspection of the microtitre wells as well as the higher absorbance values 
attained after the microtitre plate was read at 600nm. No precipitate was observed when BM2 
was combined with the fungal inoculum. It is possible that the precipitation occurred as a result 
of interaction with the culture media or interaction with the bacterial cells itself, as the same 
was not observed for C. albicans. Higher concentrations of peptides have been shown to 
precipitate in culture medium (Steinberg et al. 1997, Wu & Hancock 1999). The precipitation 
could also be related to the pH of the culture media, as the pH of the SD medium for C. albicans 
was adjusted to 7.0 ± 0.1. It may be that the pH of tryptic soy broth needed to be pH-adjusted 
prior to use. Studies have recommended preparation of peptide stocks by the addition of 0.01% 
acetic acid and 0.2% bovine serum albumin to avoid precipitation of the peptides (Steinberg et 
al. 1997, Wu & Hancock 1999). The problem, however, is that acetic acid lowers the pH of the 
medium, inhibiting bacterial growth and consequently, the antimicrobial activity of the drug 
cannot be accurately ascertained and may be overstated. 
The use of a viscous vehicle for the administration of an antimicrobial in a root canal system 
minimises dispersion of the drug into the periapical tissues and maintains it in the desired area 
for extended periods. This can be advantageous in the case of cytotoxicity. P407 exhibits a high 
degree of solubility when in contact with solutions and subsequent erosion (Garala et al. 2013). 
As shown in the in vitro stability tests, complete dissolution of P407 occurred after 4-5 days 
when in continuous contact with PBS. The gel formulation would, however, remain intact if 
not in contact with any solution but would then not release sufficient amounts of BM2. A further 
limitation with this is tubular penetration associated with limited degradation of the gel. In the 
biofilm model, it was noted that the BM2-loaded gels had not completely degraded even after 
incubation for 72 hours. The wells were washed with PBS prior to exposing the biofilms to the 
antimicrobials and hence, it can be concluded that the gel was in contact with limited solution 
leading to minimal breakdown. In a root canal model, exposure to fluids is generally minimal 
unless the antimicrobial agent is in direct contact with the periapical tissue fluids in which case 
it would be rapidly solubilised. It is possible that the P407 gels with BM2 may be stable for an 
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extended period of time in a root canal system compared to that observed in the present study 
due to the limited contact with fluids. This justifies the use and suitability of a gel medium for 
the intracanal administration of BM2 but also highlights the need for further ex vivo and in vivo 
research.  
Calcium hydroxide was chosen as a control for this study as it is the most widely used root 
canal medicament and its antimicrobial properties are based on the high pH environment it 
creates through release of hydroxyl ions (Wang & Hume 1988, Nerwich et al. 1993). In a 
clinical setting, calcium hydroxide is used in the form of a paste. The use of a paste is, however, 
precluded in this type of experimental design due to the drying out effect that would be 
problematic when conducting experiments over several days. Consequently, a saturated 
solution of calcium hydroxide was used. The biological action of calcium hydroxide will always 
occur through ionic dissociation into calcium and hydroxyl ions, however, the vehicle plays an 
important role in the overall process because it affects the concentration and the velocity of 
ionic liberation (Fava & Saunders 1999). Consequently, the results of these in vitro experiments 
cannot be extrapolated to a root canal model.  
A crystal violet assay was used for the indirect quantification of microbial adhesion and biofilm 
formation and works by binding to negatively charged surface molecules and polysaccharides 
in the extracellular matrix (Stepanovic et al. 2000, Li et al. 2003, Peeters et al. 2008). Both live 
and dead cells as well as matrix are stained making them difficult to differentiate and 
consequently, it is difficult to obtain a true representation of the cidal effects of BM2 and its 
formulations with P407 (Pitts et al. 2003). Further research using cell viability assays is needed 
and will be discussed in the following section. 
 
5.5 Future research 
This study aimed to develop a sustained release gel which possessed antimicrobial activity 
against common endodontic pathogens in planktonic cultures and biofilms.  
 
5.5.1 Antimicrobial efficacy  
The present study could be supported by further analysis including the application of confocal 
laser scanning microscopy (CLSM) where high resolution optical images are taken at various 
depths of the sample point-by-point with a laser beam and reconstructed with a computer 
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(Paddock 1999). The use of CLSM over conventional optical microscopy provides the 
advantages of controlling depth of field and elimination of background light by the use of a 
spatial filter (Paddock 1999). CLSM has successfully been used for differentiation of live cells 
from dead cells within different layers of cultured biofilms using fluorescence-based live/dead 
cell assays (Lawrence et al. 1991, Caldwell et al. 1992, Norton et al. 1998), which is limited 
with a crystal violet assay (Pitts et al. 2003). This would be useful for assessment of the biomass 
content after the development of an established biofilm, providing details on static/cidal activity 
of BM2 in P407 gel and consequently the antimicrobial activity of the formulation. 
Furthermore, the depth of penetration of BM2 within the complex biofilm structure can be 
analysed (Jefferson et al. 2005). Previous studies on BM2 used CLSM to assess the effects on 
biofilm detachment (Yoganathan 2012, Othman 2014). Yoganathan (2012) reported almost 
complete loss of cell viability of E. faecalis with BM2 at a concentration of 160 µg/mL after 
CLSM assessment, however, crystal violet biofilm assays revealed only a slight reduction in 
biofilm height with limited cell detachment.  
This study would have more clinical relevance if the antimicrobials were tested on multispecies 
and more established biofilms. Most studies examine monospecies cultures whereas nearly all 
biofilm communities comprise a variety of microorganisms with different virulence factors. 
The species that constitute a mixed biofilm and the interactions between these microorganisms 
critically influence the development and shape of the community (Elias & Banin 2012). 
Interspecies dynamics within mixed biofilms, such as communication and/or competition for 
nutrients and physical resources, represent those of a community rather than a single species 
population and hence, studies testing antimicrobials on monospecies biofilms do not 
demonstrate the true antimicrobial potential of the drug. Multispecies biofilms are thought to 
be more resistant to antimicrobial treatment (Leriche et al. 2003, Burmølle et al. 2006, Kara et 
al. 2006) and this may be related to their more complex extracellular polysaccharide matrix 
(Adam et al. 2002). This is the first study to assess the antimicrobial efficacy of BM2 
incorporated into a P407 gel. It is imperative to evaluate the efficacy of any new antimicrobial 
on monospecies biofilms to provide experimental justification before undertaking studies on 
multispecies models or ex vivo models. 
It would be beneficial to assess an ex vivo model to determine whether BM2 in a gel medium 
has the ability to penetrate dentinal tubules and reduce the bacterial load within the tubules. 
This is especially important given the complexity of the root canal system and the issues 
surrounding the presence of pulpal remanents. It is possible that a higher concentration would 
be required for BM2 to exert the same bactericidal and fungicidal effects as shown in this study 
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in infected dentinal tubules. Teanpaisan et al. (2013) used a modification of the model described 
by Haapasalo & Ørstavik (1987) and showed that the number of colonies of E. faecalis 
decreased in the deeper layers of radicular dentine. They also found no significant difference 
between the chosen antimicrobial in a P407 gel and calcium hydroxide paste.  
 
5.5.2 Poloxamer 407 
Poloxamer 407 has been shown to be a promising delivery system for BM2. Further studies 
could evaluate the rheological behaviour of BM2-loaded P407 with emphasis on the mechanism 
of BM2 release. Additionally, additives might be used to enhance the physicochemical 
properties of P407 and the release of BM2 (Choi et al. 1999, Kojarunchitt et al. 2011). 
 
5.5.3 BM2 
A mechanism of action of BM2 was demonstrated by Monk et al. 2005 in which they showed 
broad-spectrum fungicidal activity against a range of fungi by inhibition of the integral plasma 
protein Pma1p. The present study showed antimicrobial activity against the bacterial strains 
and fungal strain tested in aqueous and gel form, however, the mechanism of action against 
bacterial species is yet to be elucidated. Future research could assess the structural configuration 
of BM2 which may provide information on the mode of action on bacterial cell walls and cell 
permeabilisation. The interactions of an AMP cannot be completely explained by a particular 
sequential amino acid pattern (Fjell et al. 2012) but rather by the physicochemical and structural 
features including size, residue composition, charge, secondary structure, hydrophobicity and 
amphiphilic character (Boman 2003, Hall et al. 2003, Fjell et al. 2012). 
 
5.5.4 Toxicity 
5.5.4.1 Poloxamer 407 
Studies have reported on the nontoxic properties and stability of P407 (Johnston & Miller 1985, 
Henry & Schmolka, 1989, Garcia Sagrado et al. 1994), however, further research is needed to 





Several cationic AMPs have been shown to possess a broad-spectrum of antimicrobial activity 
against gram-negative and gram-positive bacteria, viruses, mycoplasma, and fungi (Hancock 
1997) whilst being minimally toxic to host cells (Giacometti et al. 1999). They preferentially 
interact with bacterial cells rather than mammalian cells as a result of their surface charge, 
preventing them from binding to the cholesterol-rich and neutral plasma membrane surfaces 
(Monk et al. 2005). This enables AMPs to exert their antimicrobial effects without being 
significantly toxic to mammalian cells (Monk et al. 2005). Although Monk et al. showed that 
BM2 did not cause significant haemolysis of red blood cells or death of cultured human 
epithelial type 2 cells, further investigations are warranted to assess the cytotoxicity of BM2 to 
surrounding tissues by using cell lines derived from fibroblasts, cementoblasts, and osteocytes.  
 
5.6 Conclusions 
BM2, a broad-spectrum antimicrobial, was successfully prepared as a thermoresponsive gel 
using Poloxamer 407. This study has demonstrated that BM2-loaded P407 gels not only have 
in vitro antimicrobial activity against planktonic cultures but also anti-biofilm effects. The 
antimicrobial effects of BM2 were dose-dependent and while BM2 incorporated into a P407 
gel medium required higher concentrations compared to an aqueous solution, it demonstrated 
more sustained effects on cell cultures.  
Taken together, this data indicates that BM2 in a gel medium has potential for use as an 
antimicrobial agent in the treatment of root canal infections. Further research is warranted 
assessing the ex vivo efficacy before it can be applied in an in vivo model taking into 
consideration the issues surrounding the complexity of the root canal system and the presence 
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Appendix A: Spectrophotometric analysis of BM2 
Spectrophotometric analysis of the BM2 product was carried out to establish the net peptide 
content. Table A1 shows the series of concentrations of BM2 produced and the theoretical and 
experimental absorbance values established. Absorbance values were read at 280 nm and 
revealed an actual concentration of approximately 50%. Figure A1 shows the standard curve 
for BM2 demonstrating the linear relationship between concentration and absorbance as well 
as the differences between the theoretical and experimental absorbance values. 
Table A1 Concentrations of BM2 after serial dilutions with theoretical and experimental 
absorbance values attained at 280 nm. 
Concentration 
(µM) 
Theoretical absorbance value 
(A280nm) 
Experimental absorbance value 
(A280nm) 
200 2.3 0.962 
100 1.15 0.601 
50 0.575 0.311 
25 0.2875 0.144 
12.5 0.14375 0.069 
6.25 0.071875 0.032 
3.125 0.0359375 0.011 
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Figure A1 Standard curve of BM2. The values plotted are the theoretical and experimental absorbance values attained at 280 nm.
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Appendix B: Minimum inhibitory concentration microtitre plate set up (aqueous BM2) 
 
Figure B1 Microtitre plate set up to assess minimum inhibitory concentrations of aqueous BM2. 





1 2 3 4 5 6 7 8 9 10 11 12 
A SB Empty well 128 µg/mL BM2 solution Sterile water Empty well SB 
B SB Empty well 64 µg/mL BM2 solution Sterile water Empty well SB 
C SB Empty well 32 µg/mL BM2 solution Sterile water Empty well SB 
D SB Empty well 16 µg/mL BM2 solution Sterile water Empty well SB 
E SB Empty well 8 µg/mL BM2 solution Sterile water Empty well SB 
F SB Empty well 4 µg/mL BM2 solution Sterile water Empty well SB 
G SB Empty well 2 µg/mL BM2 solution Sterile water Empty well SB 
H SB SB SB SB SB SB SB SB SB SB SB SB 
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Appendix C: Minimum inhibitory concentration microtitre plate set up (BM2 in P407 gel) 
 
Figure C1 Microtitre plate set up to assess minimum inhibitory concentrations of BM2-loaded P407 gels. 
SB = Sterile broth 
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Appendix D - Planktonic cells microtitre plate set up (BM2 in P407 gel) 
Figure D1 Microtitre plate set up to assess antimicrobial activity of BM2-loaded P407 gels against planktonic cultures. 
SB = Sterile broth 
Ca(OH)2 = Calcium hydroxide 
 1 2 3 4 5 6 7 8 9 10 11 12 
A SB 
512 µg/mL  
BM2-P407 
gel 
256 µg/mL  
BM2-P407 
gel 
128 µg/mL  
BM2-P407 
gel 
64 µg/mL  
BM2-P407 
gel 
32 µg/mL  
BM2-P407 
gel 
16 µg/mL  
BM2-P407 
gel 
8 µg/mL  
BM2-P407 
gel 
4 µg/mL  
BM2-P407 
gel 
2 µg/mL  
BM2-P407 
gel 




B SB SB 
C SB SB 
D SB SB 
E SB SB 
F SB 
512 µg/mL  
BM2-P407 
gel with SB 
256 µg/mL  
BM2-P407 
gel with SB 
128 µg/mL  
BM2-P407 
gel with SB 
64 µg/mL  
BM2-P407 
gel with SB 
32 µg/mL  
BM2-P407 
gel with SB 
16 µg/mL  
BM2-P407 
gel with SB 
8 µg/mL  
BM2-P407 
gel with SB 
4 µg/mL  
BM2-P407 
gel with SB 
2 µg/mL  
BM2-P407 
gel with SB 
0 µg/mL   
BM2-P407 
gel with SB 
SB 
G SB Ca(OH)2  Ca(OH)2 Ca(OH)2 Ca(OH)2 Ca(OH)2 Sterile water Sterile water Sterile water Sterile water Sterile water SB 
H SB SB SB SB SB SB SB SB SB SB SB SB 
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Appendix E - Planktonic cells (aqueous BM2) 
 
Figure E1 Microtitre plate set up to assess antimicrobial activity of aqueous BM2 against planktonic cultures. 
SB = Sterile broth 
  
 1 2 3 4 5 6 7 8 9 10 11 12 
A SB 
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BM2 
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2 µg/mL  
BM2 
solution 
Empty well SB 
B SB Empty well SB 
C SB Empty well SB 
D SB Empty well SB 
E SB Empty well SB 
F SB Empty well Empty well Empty well Empty well Empty well Empty well Empty well Empty well Empty well Empty well SB 
G SB Empty well Empty well Empty well Empty well Empty well Empty well Empty well Empty well Empty well Empty well SB 
H SB SB SB SB SB SB SB SB SB SB SB SB 
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Appendix F - Biofilms microtitre plate set up (BM2 in P407 gel) 
 
Figure F1 Microtitre plate set up to assess antimicrobial activity of BM2-loaded P407 gels against monospecies biofilms. Separate plates were 
set up for each exposure period. 
SB = Sterile broth 
PBS = Phosphate buffer saline 
Ca(OH)2 = Calcium hydroxide 
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Appendix G - Biofilms microtitre plate set up (aqueous BM2) 
 
Figure G1 Microtitre plate set up to assess antimicrobial activity of aqueous BM2 against monospecies biofilms. Separate plates were set up for 
each exposure period. 
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Appendix H – Minimum inhibitory concentration 
Aqueous BM2  
Table H1 Difference in absorbance after exposure to varying concentrations for aqueous BM2 for 24 hours. The OD values plotted are mean ± 
standard deviation. 
 = lowest concentration whereby no visible growth evident after 24 hours incubation 
BM2 in P407 gel  
Table H2 Difference in absorbance after exposure to varying concentrations of BM2-loaded P407 gels for 24 hours. The OD values plotted are 
mean ± standard deviation. 
= lowest concentration of BM2 in P407 whereby no visible growth evident after 24 hours incubation 
Concentration of BM2 (µg/mL) 
Mean ± SD 0 2 4 8 16 32 64 128 p value 
C. albicans 1.611 ± 0.026 1.510 ± 0.057 1.419 ± 0.068 1.224 ± 0.160 0.541 ± 0.064 0.007 ± 0.013 -0.001 ± 0.006 -0.002 ± 0.002 < 0.001 
S. gordonii 0.519 ± 0.042 0.522 ± 0.039 0.438 ± 0.022 0.059 ± 0.027 0.009 ± 0.006 0.008 ± 0.006 0.001 ± 0.004 -0.039 ± 0.018 < 0.001 
S. mutans 0.448 ± 0.021 0.410 ± 0.039 0.002 ± 0.002 0.003 ± 0.003 0.003 ± 0.001 0.005 ± 0.004 0.011 ± 0.007 -0.056 ± 0.029 < 0.001 
E. faecalis 0.404 ± 0.021 0.378 ± 0.018 0.353 ± 0.068 0.402 ± 0.016 0.350 ± 0.023 0.021 ± 0.003 0.003 ± 0.004 -0.030 ± 0.022 < 0.001 
Concentration of BM2 in 25% P407 (µg/mL) 
Mean ± SD 0 2 4 8 16 32 64 128 256 512 p value 
C. albicans 1.151 ± 0.063 1.018 ± 0.100 1.110 ± 0.143 1.197 ± 0.094 1.057 ± 0.060 1.037 ± 0.078 0.874 ± 0.066 0.319 ± 0.081 0.000 ± 0.002 -0.001 ± 0.002 < 0.001 
S. gordonii 0.289 ± 0.010 0.267 ± 0.018 0.259 ± 0.018 0.207 ± 0.010 0.197 ± 0.008 0.187 ± 0.006 0.068 ± 0.012 0.005 ± 0.003 -0.006 ± 0.007 -0.014 ± 0.011 < 0.001 
S. mutans 0.123 ± 0.010 0.114 ± 0.007 0.117 ± 0.006 0.110 ± 0.007 0.088 ± 0.006 0.002 ± 0.002 -0.001 ± 0.001 0.000 ± 0.002 0.002 ± 0.002 -0.014 ± 0.007 < 0.001 
E. faecalis 0.164 ± 0.006 0.161 ± 0.005 0.171 ± 0.005 0.165 ± 0.006 0.165 ± 0.010 0.161 ± 0.006 0.162 ± 0.008 0.147 ± 0.006 0.099 ± 0.007 0.010 ± 0.006 < 0.001 
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Appendix I – Minimum inhibitory concentration C. albicans 
Aqueous BM2 
Table I1 Absorbance values attained at 600 nm for C. albicans ATCC 10261 after exposure to 
aqueous BM2. The OD values plotted are mean ± standard deviation. 
 
BM2 in P407 gel 
Table I2 Absorbance values attained at 600 nm for C. albicans ATCC 10261 after exposure to 




Time 0 h 
(mean ± standard deviation) 
Time 24 h 
(mean ± standard deviation) 
p value 
0 0.044 ± 0.006 1.655 ± 0.023 < 0.001 
2 0.043 ± 0.007 1.553 ± 0.063 < 0.001 
4 0.043 ± 0.006 1.462 ± 0.073 < 0.001 
8 0.042 ± 0.005 1.266 ± 0.165 < 0.001 
16 0.047 ± 0.008 0.587 ± 0.071 0.001 
32 0.041 ± 0.005 0.048 ± 0.016 0.163 
64 0.042 ± 0.005 0.042 ± 0.005 0.699 
128 0.042 ± 0.005 0.040 ± 0.004 0.361 
Test agent 
Time 0 h 
(mean ± standard deviation) 
Time 24 h 
(mean ± standard deviation) 
p value 
BM2 gel – 0 0.036 ± 0.001 1.187 ± 0.064 < 0.001 
BM2 gel – 2 0.037 ± 0.002 1.055 ± 0.100 < 0.001 
BM2 gel – 4 0.036 ± 0.002 1.146 ± 0.143 < 0.001 
BM2 gel – 8 0.037 ± 0.002 1.234 ± 0.094 < 0.001 
BM2 gel – 16 0.038 ± 0.001 1.095 ± 0.059 < 0.001 
BM2 gel – 32 0.036 ± 0.001 1.073 ± 0.078 < 0.001 
BM2 gel – 64 0.036 ± 0.002 0.910 ± 0.066 < 0.001 
BM2 gel – 128 0.036 ± 0.001 0.356 ± 0.081 < 0.001 
BM2 gel – 256 0.036 ± 0.002 0.036 ± 0.001 0.490 
BM2 gel – 512 0.036 ± 0.002 0.035 ± 0.001 0.032 
Calcium hydroxide 0.079 ± 0.007 0.240 ± 0.027 < 0.001 
Sterile water 0.037 ± 0.002 1.656 ± 0.032 < 0.001 
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Appendix J – Minimum inhibitory concentration S. gordonii 
Aqueous BM2 
Table J1 Absorbance values attained at 600 nm for S. gordonii DL1 after exposure to aqueous 
BM2. The OD values plotted are mean ± standard deviation. 
 
BM2 in P407 gel  
Table J2 Absorbance values attained at 600 nm for S. gordonii DL1 after exposure to BM2-




Time 0 h 
(mean ± standard deviation) 
Time 24 h 
(mean ± standard deviation) 
p value 
0 0.051 ± 0.001 0.570 ± 0.042 < 0.001 
2 0.050 ± 0.002 0.571 ± 0.039 < 0.001 
4 0.049 ± 0.002 0.488 ± 0.022 < 0.001 
8 0.048 ± 0.002 0.107 ± 0.026 < 0.001 
16 0.049 ± 0.001 0.058 ± 0.006 < 0.001 
32 0.051 ± 0.001 0.059 ± 0.005 < 0.001 
64 0.079 ± 0.004 0.080 ± 0.005 0.754 
128 0.232 ± 0.017 0.193 ± 0.016 0.502 
Test agent 
Time 0 h 
(mean ± standard deviation) 
Time 24 h 
(mean ± standard deviation) 
p value 
BM2 gel – 0 0.036 ± 0.002 0.325 ± 0.009 < 0.001 
BM2 gel – 2 0.037 ± 0.001 0.304 ± 0.018 < 0.001 
BM2 gel – 4 0.036 ± 0.002 0.295 ± 0.018 < 0.001 
BM2 gel – 8 0.037 ± 0.002 0.244 ± 0.011 < 0.001 
BM2 gel – 16 0.038 ± 0.002 0.234 ± 0.006 < 0.001 
BM2 gel – 32 0.037 ± 0.002 0.224 ± 0.007 < 0.001 
BM2 gel – 64 0.035 ± 0.001 0.102 ± 0.012 < 0.001 
BM2 gel – 128 0.037 ± 0.001 0.042 ± 0.003 < 0.001 
BM2 gel – 256 0.041 ± 0.002 0.036 ± 0.006 0.001 
BM2 gel – 512 0.072 ± 0.009 0.059 ± 0.007 < 0.001 
Calcium hydroxide 0.167 ± 0.015 0.407 ± 0.016 < 0.001 
Sterile water 0.040 ± 0.002 0.316 ± 0.011 < 0.001 
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Appendix K – Minimum inhibitory concentration S. mutans 
Aqueous BM2 
Table K1 Absorbance values attained at 600 nm for S. mutans NG8 after exposure to aqueous 
BM2. The OD values plotted are mean ± standard deviation. 
 
BM2 in P407 gel 
Table K2 Absorbance values attained at 600 nm for S. mutans NG8 after exposure to BM2-





Time 0 h 
(mean ± standard deviation) 
Time 24 h 
(mean ± standard deviation) 
p value 
0 0.049 ± 0.001 0.498 ± 0.022 < 0.001 
2 0.048  ± 0.001 0.458 ± 0.040 < 0.001 
4 0.049 ± 0.002 0.050 ± 0.002 0.019 
8 0.048 ± 0.002 0.050 ± 0.003 0.007 
16 0.049 ± 0.002 0.052 ± 0.002 < 0.001 
32 0.052 ± 0.002 0.057 ± 0.005 0.003 
64 0.079 ± 0.008 0.089 ± 0.013 0.016 
128 0.246 ± 0.012 0.190 ± 0.027 < 0.001 
Test agent 
Time 0 h 
(mean ± standard deviation) 
Time 24 h 
(mean ± standard deviation) 
p value 
BM2 gel – 0 0.038 ± 0.002 0.161 ± 0.009 < 0.001 
BM2 gel – 2 0.038 ± 0.002 0.152 ± 0.006 < 0.001 
BM2 gel – 4 0.037 ± 0.002 0.154 ± 0.006 < 0.001 
BM2 gel – 8 0.039 ± 0.002 0.149 ± 0.007 < 0.001 
BM2 gel – 16 0.038 ± 0.002 0.126 ± 0.007 < 0.001 
BM2 gel – 32 0.036 ± 0.001 0.038 ± 0.001 0.003 
BM2 gel – 64 0.038 ± 0.002 0.037 ± 0.001 0.168 
BM2 gel – 128 0.038 ± 0.001 0.038 ± 0.002 0.812 
BM2 gel – 256 0.043 ± 0.001 0.044 ± 0.002 0.016 
BM2 gel – 512 0.071 ± 0.007 0.058 ± 0.004 < 0.001 
Calcium hydroxide 0.145 ± 0.007 0.345 ± 0.018 < 0.001 
Sterile water 0.039 ± 0.001 0.169 ± 0.014 < 0.001 
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Appendix L – Minimum inhibitory concentration E. faecalis 
Aqueous BM2 
Table L1 Absorbance values attained at 600 nm for E. faecalis JH2-2 after exposure to aqueous 
BM2. The OD values plotted are mean ± standard deviation. 
 
BM2 in P407 gel 
Table L2 Absorbance values attained at 600 nm for E. faecalis JH2-2 after exposure to BM2-




Time 0 h 
(mean ± standard deviation) 
Time 24 h 
(mean ± standard deviation) 
p value 
0 0.050 ± 0.002 0.454 ± 0.021 < 0.001 
2 0.048 ± 0.002 0.426 ± 0.019 < 0.001 
4 0.049 ± 0.002 0.402 ± 0.066 < 0.001 
8 0.048 ± 0.003 0.449 ± 0.017 < 0.001 
16 0.049 ± 0.003 0.399 ± 0.024 < 0.001 
32 0.052 ± 0.002 0.073 ± 0.004 < 0.001 
64 0.086 ± 0.005 0.089 ± 0.004 0.084 
128 0.238 ± 0.018 0.208 ± 0.009 < 0.001 
Test agent 
Time 0 h 
(mean ± standard deviation) 
Time 24 h 
(mean ± standard deviation) 
p value 
BM2 gel – 0 0.036 ± 0.001 0.200 ± 0.006 < 0.001 
BM2 gel – 2 0.036 ± 0.001 0.197 ± 0.005 < 0.001 
BM2 gel – 4 0.035 ± 0.001 0.206 ± 0.005 < 0.001 
BM2 gel – 8 0.037 ± 0.001 0.202 ± 0.006 < 0.001 
BM2 gel – 16 0.038 ± 0.003 0.203 ± 0.008 < 0.001 
BM2 gel – 32 0.036 ± 0.002 0.197 ± 0.006 < 0.001 
BM2 gel – 64 0.035 ± 0.001 0.197 ± 0.008 < 0.001 
BM2 gel – 128 0.036 ± 0.001 0.184 ± 0.006 < 0.001 
BM2 gel – 256 0.042 ± 0.002 0.141 ± 0.007 < 0.001 
BM2 gel – 512 0.068 ± 0.004 0.078 ± 0.006 < 0.001 
Calcium hydroxide 0.153 ± 0.010 0.352 ± 0.022 < 0.001 
Sterile water 0.037 ± 0.001 0.300 ± 0.007 < 0.001 
